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ABSTRACT 
This dissertation explores the use of novel detection methods for biological and 
chemical components commonly found in the environment. It encompasses two techniques: 
surface-enhanced Raman scattering (SERS) and electrochemically modulated liquid 
chromatography (EMLC). 
Immunoassays using SERS as a readout tool have been developed in this laboratory 
and have shown low levels of detection (i.e., pico- to femtomolar and single binding event 
detection) for disease and biowarfare agents. This thesis seeks to further the performance of 
this platform for bacteria detection and explore strategies to increase the SERS response. 
Specifically, the first section of this dissertation focuses on the detection of a common, 
economically devastating, bovine bacterium. By the judicious design of the assay platform, a 
selective assay for the bacteria was developed, and low levels of detection (~500 bacilli/mL) 
were achieved. Further examination of these results led to the exciting discovery of an 
amplification phenomenon based on protein shedding from the surface of the bacteria. The 
last portion of the SERS readout immunoassay research focuses on fundamental studies 
employing resonant, dye molecules to create enhanced SERS signals. Full immunoassay 
results for four dyes, when compared with our standard, non-resonant reporter, yielded SERS 
signals ~300 times more intense. Implications of signal enhancement with respect to limits of 
detection are elucidated, and future work towards decreasing nonspecific binding briefly 
introduced. 
The second part of this dissertation introduces research development in EMLC, 
specifically the use of mobile phase pH regulation and incorporation of novel stationary 
phases. By expanding upon current EMLC techniques, novel separations of weakly 
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basic/acidic compounds were achieved. These studies revealed the potential power of EMLC 
with mobile phase pH control to improve resolution while simultaneously reducing elution 
time for seven compounds. These results, which are in contrary to other reversed phase LC 
systems, are based on the ability to “pull apart” a chromatogram. In addition, the capability to 
perform a titration with EMLC, and thus determine the pKa of a compound, is discussed in 
context of acid-base equilibria. This dissertation also introduces work underway for a 
redesigned column for testing monolithic carbon materials as an EMLC stationary phase. 
Finally, insights gained during this project are used to formulate further column redesign and 
in-situ monolith formation for improved EMLC separations. 
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CHAPTER 1: General Introduction 
DISSERTATION OVERVIEW 
This dissertation represents work aimed at advancing two areas of analytical 
chemistry. Detection of chemical and biological pathogens that cause illness and affect the 
environment is of the utmost importance not only for economic purposes but also for the 
improvement of life. This dissertation is organized into six sections. Chapter 1 starts with a 
discussion of detection techniques for bacteria, highlighting the advantages and 
disadvantages to each system. In addition, this literature review will introduce surface-
enhanced Raman scattering (SERS) with emphasis on signal origin and instrumentation. Four 
original research chapters, each presented as a separate manuscript, and one appendix follow. 
Chapters 2 through 4 develop techniques for improving antigen detection, while Chapter 5 
and the Appendix discuss investigations into electrochemically modulated liquid 
chromatography (EMLC) with respect to mobile phase and stationary phase composition.  
As improvements in immunoassays and their detection methods have been pivotal in 
the advancement of bioanalytical science, the first three research chapters focus on important 
developments for a heterogeneous, two-site immunoassay.1-3 In Chapter 2 and 3, this 
immunoassay is applied to the detection of Mycobacterium avium subspecies 
paratuberculosis (MAP). Current techniques to identify this bacteria lack the sensitivity, 
selectivity, or speed necessary for reliable detection. Specifically, the immunoassay 
optimization and results for MAP lysate are introduced in Chapter 2 through application of a 
recently developed antibody specific to a MAP surface protein.4-6 Next, the assay system is 
further characterized, and a possible internal amplification mechanism for the heat-killed, 
whole cell bacteria is presented in Chapter 3. In Chapter 4, methods are developed for 
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incorporating resonance Raman molecules into extrinsic Raman labels (ERLs). The stable 
colloids are then used in a heterogeneous, two-site immunoassay for mouse IgG. Comparison 
of resonant versus nonresonant reporter molecules is made with enhancement factors, and 
limits of detection are evaluated. 
Chapter 5 and the Appendix have introductions appropriate to their EMLC studies. 
As such, EMLC background will not be part of this literature review. Chapter 5 extends the 
versatility of EMLC by evaluating how mobile phase conditions, specifically pH, affect 
retention mechanisms and techniques developed are then applied to triazines, a class of 
harmful herbicides. After the Conclusions and Prospects section, the Appendix offers a brief 
introduction to monolithic stationary phases by focusing on their potential and challenges 
associated with their integration into a standard EMLC column. 
 
LITERATURE REVIEW 
Detection of Bacteria 
The detection of pathogenic bacteria is crucial for identification of diseases in the 
healthcare, defense, food, and environmental arenas. In addition, by rapidly and correctly 
distinguishing the bacteria, appropriate measures to limit the spread of disease and actions to 
counteract infection can be taken. Analytical methods to detect, identify, and quantitate 
bacteria must be able to not only rapidly analyze a sample, but also do so selectively and 
sensitively. Moreover, because of the vast number of bacterial pathogens and varied areas 
where evaluation is needed, the techniques must be universally transferable to multiple 
bacteria types while also being cost effective. Finally, a low maintenance, continuous 
operation, easy-to-use system would be desirable. 
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The food industry accounts for the largest area of research in pathogen detection 
followed by the clinical, water, environmental, and defense fields.7 In addition, the 
complexity of food matrices can complicate pathogen detection.8 Many food borne illness 
events have made headlines in the popular press, with recent U.S. bacterial threats including 
Escherichia coli O157:H7 contamination in spinach (205 confirmed illnesses, three deaths)9 
and Salmonella tainted peanut butter (329 illnesses, 51 hospitalizations).10 
In addition to the above pathogens, the human respiratory disease tuberculosis was 
recently a target antigen for detection studies in our research group. This organism is a part 
of the Mycobacterium genus which includes bacteria that cause the human ailments of 
leprosy and ulcers.11, 12 In order to study this family of bacteria, a collaboration with the 
National Animal Disease Center (Ames, Iowa) was launched that employed Mycobacterium 
avium subsp. paratuberculosis (MAP). The pathogencity of MAP, a bacteria that is detected 
by a SERS-readout immunoassay in Chapter 2 and 3, has recently been reviewed.13 Most 
importantly, this bacterium is responsible for Johne’s disease which causes chronic enteritis 
of the intestines that leads to malabsorption of nutrients and death in cattle.  
MAP can reside in domestic ruminants (e.g., cattle, sheep,14, 15 and goats16, 17) and 
wildlife (e.g., deer,18-20 antelope,21, 22 bison,23 and rabbits24, 25). Serological surveys conducted 
by the National Animal Health Monitoring System in 1996 and 2002 indicated that 20-40% 
of the U.S. cattle herds are afflicted at some level by MAP.26, 27 In addition, it has been 
estimated that this disease imparts a economic loss of $220 million annually to the U.S. dairy 
industry,27 with an overall impact of up to $1.5 billion to the U.S. cattle industry.28 
Furthermore, this disease is characterized by intermittent, low levels of bacterial shedding 
that can slowly contaminate the surrounding environment and lead to the spread of infection. 
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However, existing methods cannot reliably detect MAP at low levels. Many of the current 
detection techniques for this and other bacteria (e.g., E. coli, Salmonella) are introduced 
below with emphasis placed on the benefits and drawbacks of each method. 
 
Traditional Methods 
Clinical/Symptomatic Diagnosis. A hallmark of bacteria infection in humans, 
animals, or plants is symptoms that are associated with the particular disease. At the forefront 
of disease detection then is clinical diagnosis through visual inspection or simple medical 
tests. For example, in tuberculosis, a respiratory disease caused by Mycobacterium 
tuberculosis, a patient will experience chest pain, coughing, weight loss, and fever.29 A 
medical professional will perform a routine examination to listen for fluid buildup in the 
lungs and obtain x-rays of the chest to look for abnormal cavities, lesions, nodules, or fibrotic 
scars that signify areas where bacteria have digested the tissue.30 In the case of MAP 
infection, the animal will have rapid weight loss and chronic diarrhea during late stages of 
infection.31 Clearly, symptoms in both diseases could be indicative of a variety of infections 
and many simple clinical procedures fall far short in yielding an exact diagnosis. Laboratory 
tests, like those introduced below, are common place and attempt to determine the bacteria 
type and strain in order to correctly identify the disease and implement treatment. 
Smear Examination. Perhaps the simplest method of detection involves smearing a 
specimen (e.g., sputum, urine, pus, pleural, cerebrospinal or biopsy) onto a glass slide.32 The 
slide can then be stained with an appropriate agent (e.g., auramine-rhodamine), viewed under 
a light microscope, and the number of bacteria enumerated (Figure 1).30 While these tests are 
generally rapid and inexpensive, the results are based on characteristics shared by multiple 
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bacteria (e.g., acid-fast bacilli staining, size, and shape) and are 
therefore only confirmation of a genus of bacteria. In addition 
bacteria levels must be high enough to be enumerated, with 104 
bacilli/mL necessary, for example, with the Ziehl-Neelsen 
method when applied to gram-positive rods of Mycobacteria.30 
For this reason, improvements in the identification of bacterium 
type are needed. 
Culture and Colony Counting. Culturing a bacterial sample is the oldest and most 
popular detection technique. This standard method relies on growing a bacteria on a selective 
media, liquid or solid, that can either inhibit growth of non-targeted strains or that changes 
physical appearance (color or degradation) of the substrate due to growth of the specified 
colony.33 Observation of colonies (e.g., size, shape, color, surface appearance, and odor) 
followed by enumeration (Figure 2) or optical density (OD) determination are used to 
classify bacteria type and evaluate the concentration. However, many of the criteria are 
subjective which can lead to errors in strain identification.34 
This technique, while well-established and sensitive, also 
suffers from long incubation (a few days to multiple weeks), 
with MAP requiring 12-16 wks.35 In addition, colonies may 
grow on top of each other thus complicating identification and 
enumeration. If two or more bacilli produce indistinguishable 
colonies, gross underestimation of the actual concentration 
occurs. As such, results are designated as colony forming units 
(CFU) per mL instead of bacilli/mL.32 
 
Figure 1: Mycobacterium 
tuberculosis (~3 μm rods) 
stained red in a sputum 
sample (from CDC, Public 
Health Image Library).  
Figure 2: Colonies of 
Mycobacterium tuberculosis 
(from CDC, Public Health 
Image Library). 
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Advances that improve sensitivity and decrease incubation time include the use of 
radiometric labeling. For example, the BACTEC Radiometric System detects 14CO2 that is 
given off as the bacteria grow on a radiolabeled, palmitic acid substrate.36 While this method 
improves upon colony counting and is more rapid, the use of radioactive materials and high 
cost limit widespread use.35 Recent advances towards the development of more specific, 
strain based tests that are sensitive and rapid are now beginning to displace these methods. 
 
Recent Advances 
Polymerase Chain Reaction (PCR). PCR was developed in 1985, and Kary Mullis 
received the 1993 Nobel prize for this invention.37 Since then, this technique has been widely 
applied to detection of bacteria.38 PCR is less time consuming than culturing, and when not 
including enrichment steps, takes only 5 to 24 h to produce results.7 In this method, DNA is 
first extracted from the source and purified. The isolated DNA is denatured by heat and then 
amplified at a cooler temperature by 
specific primers and polymerization 
enzymes (Figure 3). These heating and 
cooling cycles are repeated several times, 
creating an exponential amplification of the 
original strand.39 This material is then 
quantified, for example, through the use of 
gel electrophoresis, which in many cases is 
a detection technique on its own.40 In gel 
electrophoresis, the charged fragments are subjected to an electrical filed that forces them to 
Thermally denature DNA
Anneal Primer (at 3’ end)
Extend Primers
Cycle 1
Repeat (Denature DNA then 
anneal and extend primers)
Cycle 2
Figure 3: Basic PCR procedure, usually performed 
in a thermocycler. 
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move through the gel.34 Different masses migrate at different rates, with smaller proteins 
moving faster through the pores of the gel.41 This separation is detected by staining the 
fragments and comparing the bands to size standards. 
Variations in this basic principle include real-time PCR, multiplexed PCR, and 
reverse transcriptase PCR (RT-PCR). In real-time PCR, the sample is interrogated by 
fluorescence measurements of dye-tagged DNA. These measurements are used to follow the 
progression of the amplification process since the signal intensity is proportional to the 
amount of product.42, 43 RT-PCR has the ability to detect viable bacteria7 and can be used 
without pre-enrichment steps,44 although bacteria concentrations may need to be quite high 
(107 CFU/mL).45 In multiplexed PCR, several DNA genes, corresponding to different 
bacteria, are amplified at the same time thus allowing for simultaneous detection of several 
pathogens.46, 47 All PCR techniques have limitations48, 49 and can lack specificity if the probe 
hybridizes with DNA from similar bacteria50 or other proteins in a complex matrix. However, 
PCR can be strain specific and sensitive. 
Gamma Interferon (INF-γ). In this recently developed procedure, whole blood is 
tested for an immunological response to a specific antigen. A blood sample is mixed with the 
antigen and incubated for a specified period of time, usually 24 h. If the person or animal is 
infected, T-cells in the blood will recognize the antigen and release INF-γ in response (Figure 
4), which is measured by ELISA.51 This test is becoming more integrated into medical 
laboratories, with a commercially available kit for tuberculosis serving as a recent example.52 
However, INF- γ tests suffer from false positives because of cross reactivity with similar 
bacteria.53 Furthermore, Stabel and coworkers found that only 50 to 75% of cows in bovine 
herds that had low levels of MAP infection were identified when using an ELISA-based test 
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for INF-γ.54 Other studies have found this method to be unreliable for people who have been 
vaccinated against the disease, young children55 and calves under one year.56, 57 
 
Other Methods. Common serological tests, including complement-fixation (CF) and 
agar gel immunodiffusion (AGID), have been commonplace in bacterial testing but are 
falling out of favor due to their lack of sensitivity.58-60 Faster, more sensitive serological 
methods have been developed, including enzyme immunoassays that will be discussed in 
more detail later. In addition, flow cytometry has become a well accepted method for 
counting bacteria as well as determining the cell viability.61, 62 By using a flow system in 
which bacteria are individually detected by a sensor, sensitive and rapid concentration 
measurements can be obtained. Cells are identified via fluorescent tags which can be based 
on a fluorophore-labeled antibody or viability stains.63, 64 Viability stains (e.g., 
carboxyfluorescein diacetate for green fluorescence of viable cells and propidium iodide for 
red fluorescence of dead cells) lend an added dimension to classifying a sample. Other 
analytical instrumentation including chromatography and mass spectrometry, operating in 
solo or in tandem, are emerging as powerful techniques for separation and strain 
identification,65 but hardware size and cost presently limit the widespread use of these 
techniques. Modern immunological methods, most specifically biosensors, are emerging as 
Antigen Presenting 
Cell (APC)
+
Antigen 
(Ag)
+
Antigen 
Specific T-cell
APC 
processes Ag
APC presents  
Ag to T-cell
T-cell produces 
IFN-γ
 
Figure 4: Premise of QuantiFERON® which tests for IFN-γ response to an antigen (adapted from 
Cellestis). 
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competitive techniques through incorporation biorecognition elements for selectivity 
combined with the use of sensitive readout methods as discussed below. 
 
Biosensors for Bacteria Detection 
A newer area of bacteria detection utilizes biosensors that rely on antibodies or DNA 
probes to discriminate against interferences and cross reactivity found in the previous 
methods. The sensors are formed using well characterized immunoassay technology and then 
transduction is carried out through radiometric, optical, electrochemical, or other methods. 
The immunoassay platform will be briefly introduced, and then some of the most common 
readout techniques will be presented in this section. 
 Immunoassay Formats. Immunoassays represent a diverse area of biotechnology and 
have achieved widespread use due to the range of substances that are detected, the specificity 
that is enabled by the platform, and the sensitivity that is achieved with common detection 
methods.66 Immunoassays were developed in the late 1950’s by Berson and Yalow for the 
radiometric detection of insulin67 and then in the early 1960’s by Ekins for measuring 
thyroxine levels.68 Many assay conformations and biorecognition elements are currently in 
use, but the general techniques consist of a competitive or noncompetitive format using an 
enzyme, antibody, or nucleic acid recognition element. 
Two of the most common assays are shown in Figure 5. In the competitive 
immunoassay (Figure 5a), the analyte is mixed with labeled antigen, and the mixture is 
allowed to incubate with a capture substrate. The labeled antigen competes with the analyte 
for a limited number of binding sites, and after rinsing excess reagent, the signal for the 
labeled antigen is determined. Since the signal is inversely proportional to analyte 
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concentration, low analyte concentration yields a large signal. As a consequence, the 
detection limit is dominated by the affinity constant of the antibody with respect to the 
antigen and errors in measurement.69 
 
In the noncompetitive immunoassay (Figure 5b), an excess of binding sites are 
available to potentially capture all available analyte. The antigen-antibody complex is then 
incubated with a secondary antibody containing the label. This sandwich, or two-site, 
immunoassay is read out with the signal directly related to analyte concentration. In this case, 
the detection limit is governed by the affinity constant of the antibody, experimental error, 
and signal intensity of the label. In theory, using a “brighter” label should lead to a more 
sensitive assay, with theoretical detection limits two orders of magnitude better than 
competitive immunoassays.69 In practice, limits of detection can be hindered by the 
nonspecific interactions of the labeled antibody to the surface when no antigen is present. As 
expected, research continues to focus on approaches to minimize, and ideally eliminate, 
nonspecific binding through the use of surfactants, small proteins, blocking agents, or special 
surface coatings. 
+ +
Incubate
Rinse
+
Incubate
Rinse
Incubate
Rinse
+
(a)
(b)
Antibody
Labeled, Secondary 
Antibody
Antigen, Analyte
Labeled Antigen
 
Figure 5: (a) Competitive and (b) Noncompetitive, two-site immunoassay formats. 
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After optimization, the assay is carried out, and the antigen is quantified. In either the 
competitive or noncompetitive immunoassay, the scope of labels for readout is vast. The 
most common techniques are tied to enzymatic reactions, radiotracers, chromophores, or 
redox couples, and each will be explored further below. 
Radiotracer Detection. Radioisotope detection is usually based on the isotopic 
labeling of an antibody. Commonly used radiotracers include 14C, 3H, 32P, 35S, and 125I. Once 
labeled, the decay of the isotope is monitored and quantitated. While γ-rays (i.e., 125I) or β-
particles (i.e., 3H or 14C) can be employed, γ-emitters are more readily used because of their 
high penetrating power.70 This method is not affected by environmental conditions or 
background from biological samples,69 and the read out requires only a simple counter. 
However, radioisotopes are hazardous and have high disposal costs which, coupled with the 
performance of emerging techniques, have lead to a decline in usage. 
Optical Detection Methods. There are many options for optical detection with 
enzymatic-generated chromophores and luminescence being the most common. Advances in 
surface plasmon resonance (SPR), quantum dots (QDs), and surface-enhance Raman 
scattering (SERS) are leading to the incorporation of these methods into immunoassay 
readout as well. Since SERS detection is used throughout this dissertation, it will be explored 
in a separate section. 
In enzyme immunoassays, one of the most used approaches for pathogen detection is 
enzyme-linked immunosorbent assay (ELISA).71, 72 In a typical sandwich ELISA, antibodies 
are immobilized on a platform (usually a microtitre plate), antigen is extracted from solution, 
and an enzyme-labeled antibody is then specifically bound to the captured antigen. When the 
system is exposed to the enzymatic substrate, a colored product is produced that has an 
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intensity proportional to the amount of antigen present.73 Although ELISA may only takes a 
few hours to complete, it can suffer from poor sensitivity74-77 which can be problematic 
during early stages of infection.78 In addition, factors such as the pH, ionic strength, and 
temperature of the solution69 affect assay performance and limit universal detection. 
Luminescent methods have come to the forefront of quantification of analytes in 
immunoassays. Improvement in sensitivity and safety are achieved by using probes that 
absorb light energy at shorter wavelengths and emit at longer wavelengths (fluorescence), 
emit light during a chemical oxidation reaction (chemiluminescence), or naturally produce 
light (bioluminescence). These quantitative methods can achieve detection limits on the order 
of 10-12 M.79 Nonetheless, the instrumentation is more complex than radioisotope detection 
with the need for a light source, filters or monochromators, lenses, and detectors. While these 
readout methods are popular, there are limitations to their utility. In general, the 
chromophores have broad emission peaks that complicate their use in multiplexed scenarios. 
In addition, biological samples have a fluorescence background and scatter incident radiation 
thus interfering with the analytical signal. Furthermore, quenching of fluorescence and 
photobleaching are commonplace.69 
A new area of optical detection employs SPR sensors. When incident light is at a 
specific wavelength and angle, an evanescent electromagnetic field is produced at the surface 
of a thin metal. By scanning the incident angle and monitoring the reflected light intensity, a 
minimum reflectivity occurs when the light is coupled to the surface plasmon oscillation.80 
This condition is sensitive to the dielectric properties of the surface which are affected by a 
surface immobilized species. Shown in Figure 6 is a simplified schematic of a common SPR 
sensor configuration. In this case, a gold surface/prism interface contains adsorbed antibodies 
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that can extract antigen from flowing solution.81 The 
binding of antigen to the sensor chip results in a 
change in the refractive index of the metal/dielectric 
interface which is detected as a shift in the resonance 
angle.82 This optical method is then label-free, 
yielding a change in signal upon antigen capture. In 
addition to its use in label-less, real time analysis, 
SPR sensors have limits of detection ranging from ppb and nanomolar levels to 104 
organisms/mL.80 Disadvantages arise from refractive index changes that are not due to the 
desired complex formation and can include false-positives due to nonspecific binding, 
solution inhomogeneity, or temperature fluctuation. Furthermore, as the sensitivity is based 
on changes in refractive index at the sensor, small molecules pose a greater challenge.73 
Another recent advancement in detection stems from the use of quantum dots. QDs 
are composed of semiconductor nanocrystals, with the CdSe-ZnS core-shell being very 
popular, that are used as the label in immunoassays.83 These photostable nanoparticles are 
highly luminescent, and their emission maximum to lower energies as the size increases.84 In 
addition, these particles have bands that are both narrower and more intense than common 
molecular fluorophores. In addition, the size of the particles can be tuned for multiplexing. 
When incorporated into an assay, detection limits rival many of the available techniques, 
with 104 CFU/mL levels reached for the concurrent readout of E. coli and Salmonella in only 
2 hours.85 The biggest drawback to this technology has been the lack of biocompatible 
semiconductor surfaces,86 though advances in this area to coat and stabilize the QDs87 are 
ongoing. 
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Figure 6: Basic SPR, flow channel 
sensor that detects antibody-antigen 
binding by measuring changes in the 
reflected light. 
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Electrochemical Detection. Two general categories of electrochemical biosensors 
exist. The first is based on biocatalysis, while the second method is focused on affinity 
sensors.88 In the former method, an enzyme is coupled to an electrode through polymer 
entrapment, surface adsorption, covalent binding, electrostatics, or biospecific interactions. 
When an antigen is present that reacts with an enzyme-labeled antibody, an electrochemical 
response is detected. This technique is generally limited by the ability to create a stable layer 
of the enzyme. In the case of affinity biosensors, the immobilization of antigen and antibody 
follow the general procedures used in immunoassays. The detection is usually performed by 
interrogating a sample that has either an electrochemically tagged antigen (competitive) or 
antibody (noncompetitive).88 
After performing an assay, the ensuing change in current, potential, or impedance can 
be measured.73 In amperometric methods, the antigen concentration is linearly related to 
current, but this trend is an indirect measurement of an enzymatic reaction. With 
potentiometeric transducers, a logarithmic concentration response is often obtained, but this 
easy-to-use system can suffer from electrode fouling and low sensitivity. Impedimetric 
techniques can be used for real-time, label-free capacitance measurements due to changes in 
the thickness and dielectric properties of the electrode. These methods benefit from rapid 
readout of antigens while using inexpensive instrumentation. In addition, it is sometimes 
possible to work in turbid environments or repeat measurements,73 but these benefits are only 
possible when electrode fouling does not occur in the case of the former, and the 
sample/redox chemistry is marked by reversibility in the latter situation. Furthermore, 
electrochemical methods can be limited by low sensitivity due to nonspecific interactions and 
interferences from other solution components.7 
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Other Developments. The application of other technologies to the advancement of 
pathogen detection has been vast. In addition to those methods outlined above, force, 
magnetic, and mass detection methods have been researched. Atomic force microscopy and 
functionalized microcantilevers can be used to evaluate intermolecular interactions and 
immunosensors.89 Also, techniques that rely on scanning probe microscopy can be used to 
visually interrogate a sample substrate and enumerate the number of antigens bound.90 Giant 
magnetoresistance technology, commonly found in computer hardrives, has been applied to 
detection of magnetically labeled antigens.91 Furthermore, as piezoelectric devices advance, 
the direct detection of bacteria due to specific binding to a platform and then measuring the 
frequency change (based on mass accumulation) is being explored.92 
Many of the techniques currently being developed involve combining multiple 
methods or implementing advanced sample preparation prior to detection. With respect to the 
former, research is expanding upon using PCR to first copy the DNA present in a sample and 
then applying this amplified solution in an assay with common readout technologies to 
further improve limits of detection. For the latter, one area of growing research is the 
application of immunomagnetic beads for separation and concentration of antigens.7 Another 
technique utilizes antibody-coated paramagnetic beads to extract the analyte from solution 
prior to detection.63 
 
Surface-enhanced Raman Scattering (SERS) 
Raman Background. When particles have dimensions comparable to or smaller than 
an incident electromagnetic field and are randomly distributed in a medium of differing 
refractive index light scattering can occur. An induced secondary emission takes place from a 
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subtle distortion when the positively charged nuclei of a molecule are attracted toward the 
negative pole of the incident radiation, and the electrons are attracted toward the positive 
pole.93 This charge separation produces an induced dipole in the particle and secondary, 
elastic radiation. Another type of light scattering was first observed by C.V. Raman in 
1928.94, 95 Named Raman scattering on his behalf, this inelastic scattering is characterized by 
frequency shifts that are independent of the scattering angle and are based on vibrational or 
rotational transitions in a molecule. 
The photon origin of this process is illustrated in Figure 7. When an incident photon 
is adsorbed by a molecule into a virtual state, the excited electron can either relax by 
scattering elastically (Rayleigh) or inelastically (Raman). Raman scattering is much weaker 
(10-6 of the incident radiation intensity) than the Rayleigh scattering and has a frequency of 
the original photon shifted with respect to the vibrational frequency of the 
molecule/functional group. At room temperature, the Stokes lines are more intense than the 
anti-stokes lines because the ground-state population is greater than that of the excited state.93 
It is therefore more customary to measure the Stokes side of the spectrum. 
The closer the virtual state is to a real energy level, the higher the adsorption 
probability. When the virtual state approaches the lowest excited electronic state, pre-
resonance is achieved. When the frequency of an incident photon lies within the contour of 
an electronic adsorption band, resonant Raman scattering is obtained. This higher adsorption 
probability leads to a larger number of scattered electrons and stronger Raman signals.96  
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Classic theory leads to an equation to define the Raman effect:  
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with μin the induced dipole of a polarizable molecule, α0 the polarizability at equilibrium, Em 
the amplitude of the incident wave, νex the excitation frequency, t the time, rm the maximum 
bond separation, and νυ the vibrational frequency.93 This expression leads to the three 
scattering events, with the first term representing the Rayleigh line and the second and third 
terms representing the anti-Stokes and Stokes lines, respectively. Equation 1 also shows that 
for a mode to be Raman active there must be a change in polarizability at the equilibrium 
bond distance. 
In addition, Raman intensities can be characterized by: 
( ) kTEiexexR ienE /04 −∝Φ ννσ     (2) 
which defines the radiant power (ΦR) with respect to Raman scattering cross section σ(νex), 
source irradiance as E0, number density in the initial state as ni, and the Boltzmann factor as 
the exponential term. As the signal strength is based on irradiation intensity, laser sources 
have become popular. Also, with intensity proportional to the fourth power of the laser 
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Figure 7: Photon origin of Rayleigh and Raman scattering. 
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frequency (νex), using short wavelength (i.e., UV) lasers can be advantageous. In addition, 
increasing the cross section leads to more intense signals, so methods to optimize this term 
have been considered. However, even when optimizing these conditions, Raman is a weak 
spectroscopic technique not applicable to detection limits demanded by immunoassays. The 
advent of SERS opened the door toward a more feasible use of Raman scattering for 
immunoassay detection. 
SERS Theory. In 1974, Fleishman and coworkers observed large Raman signals 
when pyridine was adsorbed at the surface of electrochemically roughened silver 
electrodes.97 However, they described the intensities as being due to a high number of 
adsorbates. Independently, Jeanmarie and Van Duyne98 and Albrecht and Creighton99 
proposed that the signals were not merely due to surface concentration and defined the 
phenomenon as SERS. This enhancement occurs when the incident radiation couples with 
the localized surface plasmon oscillation of a coinage metal surface (e.g., gold, silver, or 
copper) and is also dependent on the shape, asperity size, and dielectric properties of the 
material.100, 101 
Raman scattering can be described by the simple equation of: 
Eαμ =in      (3) 
where the induced dipole moment (μin) is proportional to the product of the polarizability (α) 
and the electric field (E). In order to obtain enhanced signals, the electric field and/or 
polarizability must be increased. These two aspects lead to the basis of SERS theoretical 
mechanisms which are a combination of chemical (increase in α of the molecule) and 
electromagnetic enhancements (increase in E at a surface) that experimentally yield 
enhancements of 106 to 108. The chemical enhancement mechanism is based on short ranged 
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effects and has a smaller contribution (100 times) to the overall enhancement. The two main 
models, adatom102 and charge-transfer,101, 103 are based on an increase in the polarizability of 
the molecule as a consequence of adsorption onto a metal surface.104 Many contributions to 
the electromagnetic theory extist,101, 105-107 and all are based on enhanced local electric fields 
experienced by the Raman active molecule and account for at least 105 enhancement. The 
image field model,108 surface field calculations,109 and distance dependence107 of d-12 have 
been recently reviewed by Driskell et. al.110 
In SERS, the signal intensity is a combination of effects represented by: 
( ) ( ) ( ) ( ) adsorbedscLLscSERS AAINI σνννν ××××= 22'    (4) 
with the number of adsorbates (N’) and the cross section (σadsorbed) leading to the chemical 
enhancement and the laser field enhancement A(νL) and the scattered field enhancement 
A(νsc) contributing to the electromagnetic effects.111 Based on equations 2 through 4, 
increasing the molecular parameters of polarizability or Raman scattering cross section 
would further increase the intensity of scattered radiation. This situation is the case with 
resonant molecules because there is a large change in molecular geometry during the 
electronic transition.93, 96 This method is the basis of Chapter 4 for achieving detection limits 
of 10-12 M. 
 
SERS Instrumentation 
Recent advances in Raman instrumentation are allowing for highly portable, low cost 
instruments that yield high sensitivity. Previously, Raman instrumentation required high 
power lasers, double and triple monochromators, specialized detectors, and vibration 
isolation at costs and sizes that complicated field deployment. With the advent of fiber optics, 
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diode lasers, improved optical filters, and advanced array detectors, Raman spectroscopy is 
now taking its place in modern analytical equipment with applicability to varied 
environments at affordable costs.112 
General Components. A Raman instrument consists of a laser source, a sample cell 
or platform, a wavelength selector, a radiation transducer, and a signal processor/readout 
system.93 The selection of the laser source is highly dependent on the sample, with helium-
neon (632.8 nm), argon ion (488.0, 514.5 nm), and krypton ion (530.9, 647.1 nm) lasers 
being among the most widely used. In addition, deep-UV lasers are coming into popularity 
for resonance measurements of biological samples,113 along with diode lasers for low-cost 
and versatility.114 As Raman theory states (Equation 2), the scattered intensity increases with 
respect to νex4, so using lower wavelength lasers can yield higher signals. However, red laser 
light from a HeNe laser, for example, can be used to reduce fluorescence background from 
some samples. In addition, if a sample is photosensitive, the wavelength of the laser and 
power density in the irradiated sample area must be considered. As a rule, the best choice is a 
compromise between high signal intensity, low interference (fluorescence), and minimal 
photodegradation. 
As Raman spectroscopy is amenable to many sample states (solid, liquid, or gas), the 
cells and platforms are quite varied.93 For liquid samples, capillary tubes or cuvettes made of 
glass or quartz are generally used, with research into design flow-through systems underway 
in many groups.115-117 An advantage of Raman over other vibrational spectroscopy 
techniques (i.e., IR) is that water is a very weak Raman scatterer, so measurements can be 
made in aqueous solutions thus allowing in situ studies of biological samples. Solid powders 
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can be placed in standard capillary tubes, in potassium bromide pellets, or on a level 
platform. 
Wavelength selectors in Raman spectroscopy are employed to achieve a spectral 
resolution on the order of 5 cm-1 and to separate the weak Raman lines from the intense 
Rayleigh radiation. For this purpose, double or triple monochromators with ruled gratings 
have been incorporated into Raman instrumentation. Advances in holographic grating 
technology, as well as improvements in filters, have allowed simplification of Raman 
instrumentation and greater signal throughput. While traditional Raman instrumentation uses 
photomultiplier tubes or dc signal processing, diode arrays are becoming popular for their 
rapid and complete spectrum acquiring capabilities. Other advances in Raman 
instrumentation include the combing techniques such as Raman microprobes118 in which a 
spectrometer is combined with optical microscopy and Fourier transform Raman 
spectroscopy.119 
NanoRamanTMI. In our laboratory, the 
standard Raman instrument is a NanoRamanTMI. This 
instrument, manufactured by our collaborator 
Concurrent Analytical and shown in Figure 8, consists 
of no moving parts and is light weight (14 lbs, 16×8×8 
in. footprint), which allows integration into many 
laboratory and industrial settings.  
The light source is a 30 mW HeNe laser with a wavelength of 632.8 nm. To transmit 
the laser excitation and collect the scattered radiation from the sample, a bifurcated fiber 
optic cable (50 μm) is attached to a fiber-optic probe head (Figure 9). The laser light enters 
A
B
C
D
 
Figure 8: NanoRamanTMI 
configuration with the spectrometer 
(A), HeNe laser (B), fiber probe head 
(C), and sample platform (D) on an 
optical table with 1” between holes.
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the fiber and is collimated by a spherical lens. After traveling through a bandpass filter (OD 
4) that removes any spontaneous Raman or fluorescence from the fiber but passes the laser 
wavelength, the light is sent through a mirror and focused onto the sample via an objective. 
The objective can either be set for solution measurements (numerical aperture (NA) of 0.40 
and working distance (WD) of 6.24 mm) or solid substrate detection (NA of 0.68 and WD of 
3.1 mm). With the latter objective, a 25-μm diameter laser spot size is incident on the 
substrate with a power of ~3 mW. The scattered radiation that is then collected reflects off a 
gold-coated mirror and is sent through a longpass filter (OD 6) that rejects the Rayleigh and 
anti-Stokes scattering. The Stokes scattered radiation is then collimated and transferred to the 
spectrometer. 
The spectrograph is an f/2.0 Czerny-Turner imaging spectrometer as shown in Figure 
10. Light enters from the 50-μm diameter fiber and is collimated by the first achromat. The 
gold mirrors that follow are used to optimize the scattered radiation angle to the grating and 
allow the system to be compact. After passing through another achromat to remove 
chromatic aberration, the scattered radiation reaches the detector, a thermoelectrically cooled 
(Kodak 0401E) charge coupled device that has a spectral resolution of 6 to 8 cm-1 (2 cm-
1/pixel). This small chip (8.4×5.5 mm) has a low dark current (less than 10 pA/cm2 at 25°C) 
and has high signal collection. Spectral integration times can be varied with most acquisitions 
at one second, controlled by a PC with Windows Visual Basic program. 
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As a final consideration for this instrumentation, CCD performance was evaluated for 
linearity throughout the dynamic range of the detector. For the current system, the CCD 
becomes nonlinear when it reaches half-capacity (Figure 11a), and a simple equation can be 
used to determine the percentage that the observed signal deviates from the true signal 
(Figure 11b). This model can be to used better evaluate antigen concentration, especially for 
the intense Raman scatters that were investigated in Chapter 4 where the signal reported by 
the CCD can be adjusted to the actual value of scattering. 
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Longpass FilterSpectrometer 
Collection Fiber
Objective
 
 
Figure 9: Schematic of instrument configuration with fiber optic probe head optics shown in black 
dashed box. 
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Figure 10: Modified Czerny-Turner imaging spectrometer.
 
24 
 
CONCLUSIONS 
In conclusion, many modern techniques can be used to develop sensitive, selective, 
and rapid detection methods for interrogating bacteria laden samples. Evaluation of these 
pathogens is important in multiple fields, with food safety and disease detection the 
motivation for research presented in this dissertation. At the forefront of the most recent 
advances, SERS-readout of two-site immunoassays has recently been developed and has 
been shown to allow for low levels of detection. In addition, SERS instrumentation offers the 
reliability, sensitivity, and ease-of-use demanded by laboratories and industry. With these 
considerations in mind, continued research and improvement could allow this technique to be 
integrated in diagnostic laboratories and field-monitoring for the screening of bacteria 
leading to timely measures for containment of contamination and correct therapeutics for 
those infected. 
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ABSTRACT 
A sandwich immunoassay is developed for the rapid, low-level detection of 
Mycobacterium avium subsp. paratuberculosis (MAP). MAP is the causative agent of 
Johne’s disease in cattle. One of the major obstacles in controlling the spread of this disease 
is the inability to rapidly detect small amounts of bacteria or other diagnostic makers shed 
during the subclinical stage of infection. This paper details the development and performance 
of an assay for sonicated MAP lysate that is based on surface enhanced Raman scattering 
(SERS). There are two key components of the assay: (1) using an immobilized layer of 
monoclonal antibodies that target a surface protein on the microorganism; and (2) tagging of 
captured proteins by extrinsic Raman labels (ERLs) that are designed to selectively bind to 
the captured protein and produce large SERS signals. By correlating the number of MAP 
bacilli present prior to sonication and the amount of total protein in the resulting sonicate, the 
 
31 
detection limit determined for total protein can be translated to the microorganism 
concentration. These findings yield detection limits of 500 and 1000 MAP/ml for sonicate 
spiked in phosphate buffer and in whole milk, respectively. Moreover, the time required to 
complete the assay, which includes sample preparation, antigen extraction, ERL incubation, 
and read out, is less than 24 h. The potential for incorporation of this assay into diagnostic 
laboratories is also briefly discussed. 
 
INTRODUCTION 
Johne’s disease is responsible for devastating losses in worldwide dairy production 
(52). The causative agent of this disease is Mycobacterium avium subsp. paratuberculosis, 
referred to hereafter as MAP. MAP has been found in domestic ruminants (e.g., cattle, sheep 
(38, 43), and goats (53, 54)) and wildlife (e.g., deer (27, 40, 41), antelope (8, 23), bison (64), 
and rabbits (6, 7, 33)). Based on a serological survey conducted by the National Animal 
Health Monitoring System in 1996 and 2002 (58, 61), 20-40% of the cattle herds in the 
United States are afflicted at some level by MAP. Moreover, the 1996 report projected that 
the annual economic impact on the United States dairy industry from this disease exceeds 
$220 million (61). 
Cattle are often exposed to MAP as calves (56). The disease develops through four 
stages and is generally diagnosed by symptomatic assessment and, when possible, 
quantification of shed bacteria. The four stages of progression are: silent, subclinical, clinical, 
and advanced cellular infection (63). During the silent stage, animals do not shed detectable 
amounts of the bacteria and are asymptomatic. In the subclinical phase, cattle shed small 
amounts of MAP in their feces and milk (e.g., 10 CFU per 50 ml of milk (29)) but still at 
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levels that are difficult to rapidly and reliably detect. This subtle level of shedding, 
nevertheless, can contaminate the surrounding habitat and spread MAP throughout a herd 
before its presence is detected. In the clinical phase of infection, the pathogen is shed at high 
levels, which can exceed 1010 organisms/g of feces (11). Symptoms during the terminal, 
advanced cellular infection stage of the disease are exemplified by chronic diarrhea, rapid 
weight loss, diffuse edema, reduced milk production, and infertility. 
There is a wide range of tests for MAP. Bacteriologic culture is the most accepted 
method and benefits from easy-to-use hardware. When coupled with symptomatic evaluation, 
culturing provides data central to distinguishing between clinical and subclinical stages of 
Johne’s disease. Culturing, however, typically requires 12 to 16 weeks of incubation (32). 
Serological tests, including complement fixation (CF), agar gel immunodiffusion (AGID), 
and enzyme-linked immunosorbent assay (ELISA), reduce testing time but can lack the 
sensitivity needed to detect MAP at subclinical levels (12-14, 16, 50, 51, 63). Methods that 
test for cellar immunity, such as the response to delayed-type hypersensitivity (DHT) and 
detection of elevated levels of gamma interferon (INF-γ), are also rapid but are indirect and 
can suffer from false-positives (31). Nucleic acid levels, after PCR amplification and gel 
electrophoresis analysis, can be determined in under three days (32) and can detect 10 MAP 
in a 2-ml milk sample when using immunomagnetic concentration (35). There are, however, 
challenges related to specificity (15, 24) and performance in complex sample matrices (35). 
It is therefore clear that improvements in sensitivity, selectivity, sample workup, speed, and 
detection are requisite in order to more effectively protect healthy animals against infection 
and the subsequent development and spread of Johne's disease (10).  
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This work explores the potential of surface-enhanced Raman scattering (SERS) to 
serve as a readout method for the low-level detection of MAP. Several laboratories, including 
our own, have demonstrated the merits of SERS readout in immunoassays (1, 19, 20, 30, 42, 
44, 45, 49, 65, 67) and DNA detection (9, 25, 28). In SERS, roughened metal surfaces 
amplify the Raman scattering of an adsorbed organic molecule. This enhancement is mainly 
due to increases in the electromagnetic field at the nanometric asperities of roughened, 
coinage metals (e.g., silver and gold). The same mechanism is operative at the surface of 
metallic nanoparticles. Coupled with potential contributions from chemical effects, 
enhancements of up to 1014 have been reported (36). 
Detection by SERS has several potentially valuable attributes with respect to 
traditional signal transduction methods such as radioisotope decay, colorimetry, and 
fluorescence (26, 39, 44). First, when employing gold nanoparticles, excitation in the red 
spectral region is used, which minimizes possible interference from native fluorescence. 
Second, SERS intensities for immobilized molecules are beginning to approach those of 
fluorescent dyes, and have the added feature of being less susceptible to photobleaching. 
Finally, the widths of Raman spectral bands are typically 10-100 times narrower than those 
of fluorescence, which reduces the potential for spectral overlap from multiple labels. The 
work herein seeks to take advantage of the first two attributes for the development of a rapid 
and highly sensitive assay for MAP. 
Our SERS-based strategy uses extrinsic Raman labels (ERLs) as a means to 
quantitatively take advantage of amplified scattering (20-22, 30, 44-48). ERLs (Figure 1A) 
incorporate the intrinsically strong Raman scattering from aromatic compounds (i.e., reporter 
molecules). In this assay, the organic molecule is first immobilized on the gold nanoparticles, 
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and then the molecule is coupled to a molecular recognition element (e.g., an antibody). The 
preparation of the capture substrate (Figure 1B) employs the same chemistry, with the 
coupling molecule forming a gold-bound thiolate and then reacting with the primary amines 
on antibodies. We note that the depictions in Figure 1 are idealized with respect to the 
architectures of the immobilized antibodies. A more random distribution of orientations is 
expected because of the presence of amine residues throughout the structure of the protein 
(18). The sandwich immunoassay (Figure 1C) can then be carried out in fewer than 24 h by: 
(1) extracting the antigen from solution; (2) labeling with ERLs; and (3) quantitating the 
antigen by SERS. We have previously applied this platform to the detection of 
immunoglobulin G (44), free prostate specific antigen (PSA) (30), viruses (20), and 
simulants of biological warfare agents (45). These works have shown that our SERS-based 
immunoassay not only offers low-levels of detection (e.g., ~30 fM for PSA in human serum) 
but also can record single-binding events on a capture substrate (47). 
This paper and the companion manuscript explore the adaptation of a highly sensitive 
SERS-based immunoassay system as a diagnostic platform for MAP. We use a recently 
developed antibody that selectively targets proteins located at the outer surface of MAP cells 
(2) and screen for activity and cross reactivity after immobilization. After optimizing 
blocking conditions and incorporating the most effective antibody into the capture substrate 
and ERLs, K-10 MAP sonicate is assayed. By correlating the number of MAP present prior 
to sonication with the amount of total protein in sonicate solution, detection limits of ~500 
and ~1000 MAP/ml for sonicate spiked in phosphate buffer and in whole milk, respectively, 
are achieved. The companion paper extends detection to whole cell MAP and investigates the 
possibility of signal amplification from shed protein. Taken together, this method is a 
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specific, sensitive, and rapid test for Johne’s disease that could efficiently track MAP 
infection. In addition, the quantitative nature of this technique could allow for more precise 
definitions of the disease stages (e.g., clinical versus subclinical) in terms of bacteria levels in 
feces and milk. 
 
MATERIALS AND METHODS 
Bacteria and sonicate preparation. Heat-killed, whole-cell MAP (K-10 bovine 
isolate) were grown at 37°C in Middlebrook’s 7H9 medium (Becton Dickinson, 
Cockeysville, MD) that was supplemented with 2 mg of mycobactin J/l (Allied Monitor Inc., 
Fayette, MO), 10% oleic acid albumin-dextrose complex (Difco, Detroit, MI), and 0.05% 
Tween 80 (Sigma Aldrich, St. Louis, MO). The bacilli, harvested from the culture media by 
centrifugation at 10,000g for 20 min, were washed twice with cold phosphate buffered saline 
solution (PBS; 0.15 M, pH 7.2). Following washing, the bacteria were either heat treated 
(80°C for 30 min) or sonicated. 
Whole-cell sonicated extracts of MAP (K-10 sonicate) in PBS (pH 7.4) were 
produced as described previously (62). After culturing MAP to an optical density of 0.2 to 
0.4 at 540 nm (OD540) and centrifuging, the pellet was resuspended in PBS and was 
sonicated. Sonication used a probe sonicator and consisted of three, 10-min cycles at 18 W 
on ice, with 10-min chilling periods between sonications. Debris was removed by 
centrifugation (12,000g for 5 min), and supernatants were harvested and stored at 20°C.  
The concentrations of the stock solutions of heat-killed, whole-cell bacteria were 
determined by: (1) flow cytometry using LIVE/DEAD® BacLight™ Bacterial Viability and 
Counting Kit (Molecular Probes, Eugene, OR); (2) bacterial enumeration through serial 
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dilution plating on Herrold’s egg yolk slants containing mycobactin J (2 mg/l); and/or (3) 
OD540 measurements. The average value for the stock solutions used in immunoassay 
development was 1.3±0.3×107 bacteria/ml (six samples of MAP in PBS). For the stock 
solutions that were sonicated, the bacteria concentration (pre-sonication) was determined to 
be 5×106 MAP/ml. After sonicating, the solution had a total protein concentration of 1 mg/ml 
as determined by absorbance measurements at 280 nm with a ND-1000 Spectrophotometer 
(NanoDrop Technologies, Inc., Rockland, DE). This value was further confirmed by using 
the Bio-Rad protein assay (Richmond, CA). 
 Heat-killed Salmonella typhimurium and heat-killed Escherichia coli O157:H7 were 
gifts from Nancy Cornick (Department of Veterinary Microbiology and Preventive Medicine, 
Iowa State University, Ames, IA). 
Preparation of Sonicate Spiked Samples in PBS and Whole Milk. Antigen 
solutions were prepared by serial dilution of the stock, K-10 sonicate with 10 mM PBS (pH 
7.4, 10 mM phosphate buffered saline powder packs, Sigma-Aldrich) or pasteurized, whole 
milk. Between dilutions, solutions were mixed by vortexing. Distilled water, subsequently 
deionized with a Millipore Milli-Q system (18 MΩ, Billerica, MA), was used for the 
preparation of all aqueous reagents. For assays in a milk matrix, whole milk at room 
temperature was employed in place of PBS during serial dilution. Specifically, the first 
dilutions were prepared by adding 10 μl of 1 mg/ml sonicate in PBS to either 10 μl of whole 
milk (5×105 ng/ml) or 90 μl of whole milk (105 ng/ml), and serial dilutions with whole milk 
were continued from these concentrations. 
Antibodies. Monoclonal antibodies (mAbs) to MAP2121c, a MAP surface protein, 
have recently been produced (4). Three monoclonal antibodies (8G2, 13E1, and 12C9), the 
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former two specific for the MAP2121c protein, were tested for performance after purification 
using Melon Gel (Pierce, Rockford, IL). This step removes extraneous proteins from the 
tissue culture supernatants that could potentially compete with mAb immobilization. The 
concentrations of the mAb solutions were determined spectrophotometrically (ND-1000, 
standard mass extinction coefficient of 13.7 L g-1 cm-1 for 10 mg/mL IgG solution), and all 
mAb dilutions employed 50 mM borate buffer (pH 8.3 borate buffer packs, Pierce). 
ERL Preparation. The design, preparation, and optimization of the ERLs were 
detailed in our previous work (20). Briefly, 1.0 ml of 60-nm gold particles (<8% variation in 
diameter, 2.6 x 1010 particles/ml, Ted Pella, Redding, CA) were added to a centrifuge vial. 
The pH of the suspension was adjusted with 40 μl of 50 mM borate buffer (pH 8.3). To this 
colloidal suspension, 10 μl of 1.4 mM DSNB (i.e., 5,5’-dithiobis (succinimidyl-2-
nitrobenzoate)) in acetonitrile (HPLC-grade, Fisher, Pittsburgh, PA) were added. DSNB was 
synthesized according to previously described methods (30). DSNB coats the gold 
nanoparticles through chemisorption as the corresponding thiolate. After 7 h, 20 μg of one of 
the three mAbs were added to the mixture and incubated for ~14 h. At pH 8.3, the amines on 
the mAb are deprotonated and form an amide linkage upon reaction with the succinimidyl 
esters of the DSNB-based monolayer. Finally, to block unreacted succinimidyl esters, as well 
as stabilize the colloidal solution, 100 μL of 10% bovine serum albumin (BSA, Sigma-
Aldrich) in 2 mM borate buffer were added to the suspension and allowed to react for 7 h.  
Next, the colloidal suspension was centrifuged (Eppendorf MiniSpin, Westbury, NY) 
at 2,000g for 10 min at room temperature to remove excess reagents. After decanting the 
clear supernatant, the loose colloidal gold pellet was resuspended in 1000 µl of 2 mM borate 
buffer containing 1% BSA. This centrifugation/resuspension procedure was repeated twice to 
 
38 
maximize excess reagent removal. The volume after the last resuspension step was 500 µL. 
Finally, 50 µL of 10% sodium chloride (Sigma-Aldrich) were added to the suspension which 
was then passed through a Costar 0.22-µm syringe filter (Fisher) in order to remove any 
aggregates. 
Capture Surface Preparation. The fabrication of the capture substrate followed past 
procedures (20, 30, 44, 45). Template stripped gold (TSG) was prepared by resistively 
evaporating ~300 nm of gold (99.9%) at 0.1 to 0.2 nm/s onto a 4-in, p-type, test grade silicon 
[111] wafer (University Wafer, South Boston, MA) using an Edwards 306A evaporator. 
After applying cleaned 1×1 cm glass chips to the gold surface via two-part epoxy (Epo-tek 
377, Billerica, MA) and oven curing at 150°C for 1.75 h, the glass slides were carefully 
separated from the wafer, exposing a smooth gold surface.  
A poly(dimethyl siloxane) (PDMS, Dow Corning, Midland, MI) stamp with a 
centered, 3.2-mm diameter hole was soaked in a 2 mM octadecanethiol (ODT, Sigma-
Aldrich) ethanolic solution. The stamp was dried under a stream of high purity nitrogen. The 
TSG substrates were then inked (~30 s) with the ODT coated-PDMS stamp. This procedure 
formed a hydrophobic barrier that surrounded a 3.2-mm assay address. These samples were 
subsequently exposed to a 1 mM ethanolic (Aaper, Shelbyville, KY) solution of 
dithiobis(succinimidyl propionate) (DSP, Sigma-Aldrich) for ~14 h which formed a DSP-
derived monolayer within the address area. After rinsing with ethanol and drying under a 
stream of nitrogen, 20 µl of capture antibody (100 µg/ml) were dispensed onto each 
substrate. This step couples the antibody to the DSP-based monolayer by the same 
mechanism as that for DSNB. After incubation for 7 h in a humidity chamber, the substrates 
were rinsed three times with 2 ml of 10 mM PBS buffer. Unreacted succinimdyl endgroups 
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of the monolayer were “capped” with a 20 µl drop of blocking buffer ~14 h (i.e., SuperBlock 
and StarterBlock (Pierce); 5% BSA in PBS, 2% Carnation dry milk in PBS, or Casein 
blocking solution (Sigma-Aldrich)).  
Immunoassay Procedure. After blocking, the capture surface was exposed for 7 h to 
either heat-killed, whole-cell 1.0×107 MAP/ml or varying concentrations of K-10 sonicate in 
10 mM PBS (pH 7.4) at room temperature in a humidity chamber. After rinsing three times 
with 2 mM borate buffer (pH 8.3, 150 mM NaCl), a 20-μl drop of the ERLs was placed on 
the substrates and allowed to react ~14 h. The substrates were again washed with the 2 mM 
borate solution, gently dried with nitrogen, and the SERS spectra collected. This procedure 
follows that depicted in Figure 1C. 
SERS Measurements with a NanoRaman™ I Spectrometer. Raman spectra were 
collected using a NanoRaman™ I spectrometer (Concurrent Analytical, Waimanalo, HI). 
This instrument consists of a HeNe laser (632.8 nm, 30 mW, 25-μm diameter spot size), 
fiber-optic-based probe head, an f/2.0 Czerny-Turner imaging spectrometer (6-8 cm-1 
resolution), and a thermoelectrically cooled CCD (0°C, Kodak 0401E). The laser light was 
focused as a 25-μm spot (2-3 mW) onto the substrate surface at normal incidence via an 
objective with a numerical aperture of 0.68, which also collected the scattered radiation. 
Exposure times of 1-s were employed with an average of four or five measurements, as noted 
in the Results section, collected from different locations on each sample. 
 
RESULTS 
Antibody Screening. As shown in our previous work on feline calicivirus (37), 
candidate antibodies should be screened in order to determine those that are the most 
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effective at binding the antigen after immobilization on the capture substrate (34). As such, 
Dot Blot reactivity with heat-killed, whole cell MAP was used to narrow a pool of eight 
mAbs, selected from an ongoing Johne’s Disease Integrated Program (JDIP) project (4, 5), to 
three. These three were designated 13E1, 12C9, and 8G2. Both 13E1 and 8G2 react with 
different epitopes on MAP2121c (4) and 12C9 binds to an unidentified MAP protein (5). 
After purification, each antibody was tested by performing an immunoassay with an antigen 
concentration of 1.0×107 MAP/ml and a PBS blank.  
Using the sensor platform depicted in Figure 1, the SERS spectra shown in Figure 2 
were obtained. The strongest feature in each spectrum (1336 cm-1) is assigned to a symmetric 
nitro stretch (νs(NO2)), while the less intense band (1588 cm-1) is diagnostic of an aromatic 
ring mode. These and all the other spectral features that are present are consistent with those 
expected for the DSNB-derived monolayer. Furthermore, the evolution of the intensities of 
the these features is indicative of the amount of ERLs and thus antigen bound to the surface; 
that is, a larger SERS signal is diagnostic of a higher level of captured antigen. The signal for 
νs(NO2) in each assay, as obtained from measurements at four locations per sample, was 
293±75 cts/s for 8G2, 223±80 cts/s for 12C9, and 1611±63 cts/s for 13E1. The blank, 
performed with 13E1, had a signal of 256±21 cts/s. Thus, 13E1, with the largest SERS 
intensity and approximately the same blank signal as for 12C9 and 8G2, was the most 
effective of the mAbs for our heterogeneous immunoassay. 
These samples were also examined by light microscopy. The images showed that 
only 13E1 substrates captured an observable amount of MAP, which is roughly a 1.5×0.5 μm 
rod. In contrast, the substrates coated with 12C9 or 8G2 exhibited little evidence for binding 
(data not shown). Based on the combined weight of these two sets of results, 13E1 was 
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chosen for the remainder of the studies. It is important to note that while 12C9 and 8G2 
mAbs had higher titers and stronger immunoblot responses (J. P. Bannantine, unpublished 
data), 13E1 was more effective when immobilized on the capture substrate. This exemplified 
the importance of screening mAbs after being tethered to substrates in a heterogeneous 
immunoassay (17, 37). 
Cross Reactivity. Specificity is another important figure of merit for diagnostic 
methods. Cross reactivity studies of 13E1 with other closely related Mycobacteria have 
recently been performed via immunoblots (4). Those studies revealed 13E1 also reacted with 
Mycobacterium avium complex (MAC) members. However, and more importantly, there was 
a lack of detectable cross reactivity with M. bovis, the other Mycobacterial pathogen in 
cattle, as well as non-MAC Mycobacteria which could also be present in bovine feces or 
milk.  
To further assess the specificity of 13E1, especially after immobilization on the 
substrate, cross reactivity studies were performed by using two commonly occurring bacteria 
in bovine milk and feces: E. coli O157:H7 (57) and Salmonella typhimurium (59, 60). These 
assays were therefore carried out with 13E1 platforms and either E. coli or S. typhimurium as 
a potential cross reactor. After exposing the samples to ERLs, the intensity for νs(NO2) was 
obtained. As shown in Figure 3, the results yielded 231 ± 16 cts/s for the PBS blank (no 
bacteria), 279±23 cts/s for 1.0×108 cfu of E. coli O157:H7/ml, and 135±15 cts/s for 7.3×109 
cells of S. typhimurium/ml. While more exhaustive cross reactivity studies remain to be 
performed, these results indicate there is no loss in selectively when 13E1 is immobilized on 
the capture substrate.  
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Blocker Optimization. As part of an optimization protocol, studies were performed 
to determine which blocking agent would minimize the blank signal while maximizing the 
response for MAP. To this end, solutions of SuperBlock, StartingBlock, 5% BSA in PBS, 2% 
dry milk in PBS, Casein based blocker, or PBS (no blocker) were placed on separate 13E1 
substrates. These substrates were then exposed to PBS (blank) or to a solution containing 
1.0×105 MAP/ml. The results from the SERS readout of each sample are summarized in 
Figure 4. The samples treated with StartingBlock had the highest signal for MAP but, 
according to the blank response, also had the highest level of nonspecific adsorption of ERLs. 
Moreover, the blocking solutions of 5% BSA, 2% dry milk, and Casein failed to remain 
confined in the 3.2-mm sample address because of their low surface tension. This “drop 
spreading” led to low signals for the MAP-containing samples. While PBS (no blocker) and 
SuperBlock have roughly the same blank and MAP signals, the precision of the measurement 
was three times better for SuperBlock. Based on these results, SuperBlock was used in the 
subsequent studies. 
Spiked PBS Samples. The K-10 sonicate samples, with concentrations ranging from 
1×102 to 5×105 ng/ml, were incubated with the capture platform (Figure 1B). After rinsing, 
the substrates were exposed to ERLs (Figure 1C). Importantly, these two steps, as well as 
those involved in sample preparation (e.g., sonication), require less than 24 h to complete. 
The resulting SERS spectra, read out in only 1 s, and calibration curve, prepared by 
subtracting the background at 1225 cm-1 from the intensity of νs(NO2) at 1336 cm-1, are 
shown in Figure 5. As evident, the SERS signals increased in a concentration-dependent 
manner with sonicated antigen. The lowest detectable signal, as defined by the blank signal 
plus three times its standard deviation, is denoted by the dashed line in the calibration curve. 
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The limit of detection (LOD), which corresponds to the intersection of these two curves, was 
calculated to be ~100 ng/ml. Since the original solution (5×106 MAP/ml) produced 1 mg/mL 
of protein, the LOD for the K-10 sonicate is ~500 MAP/ml. 
Spiked Milk Samples. To determine the feasibility of analyzing relevant biological 
samples, an initial study was performed using a milk matrix. Room temperature, pasteurized, 
whole milk was spiked with the K-10 sonicate for concentrations up to 5×105 ng/ml. As 
before, the assay procedure was performed in fewer than 24 h, with the resulting calibration 
curve shown in Figure 6. Importantly, the milk matrix plot is strongly similar to that of the 
PBS matrix in Figure 5b. That is, the close agreement between the best fit lines (i.e., slopes 
and y-intercept) and precision (i.e., standard deviations for individual samples) indicate that 
the performance achieved in the clean, PBS matrix is not compromised when using the much 
more complex whole milk matrix. Furthermore, the plot in Figure 6 translates to a LOD of 
~200×102 ng/ml (~1000 MAP/ml). These findings elucidate the robust nature of our assay 
system with respect to its potential application in complex matrices. These results also 
demonstrate that analysis in whole milk can be carried out with little sample workup. 
 
DISCUSSION 
There is a wide range of diagnostic tests for Johne’s disease, each with the previously 
detailed strengths and limitations in performance. In order to protect healthy animals from 
this disease and minimize its spread, a more effective means to identify infected cattle, track 
disease development, and characterize clinical stages are necessary. The results herein 
demonstrate that our SERS-based immunoassay can potentially address these needs and be 
readily extended to complex matrices like milk. LODs for the K-10 sonicate, obtained in 24 
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h, are ~500 MAP/ml in PBS and ~1000 MAP/ml in pasteurized, whole milk. This level of 
performance is a direct result of our integration of the 13E1 antibody as a recognition 
element with SERS as a readout tool.  
Several key features of this assay offer advantages over current detection techniques. 
First, INF-γ detection, as an indirect method, can be problematic because of false-positives. 
PCR, while a direct method, may yield false-negative results in complex matrices (55). 
Immunoassay techniques, including ELISA and our SERS-based immunoassay, show 
improvements over INF-γ detection and PCR by incorporation of antibody recognition. In 
our system, the 13E1 mAb targets a surface protein (MAP2121c) that plays a role in the 
MAP invasion of epithelial cells (3). The screening and cross reactivity studies carried out 
earlier (4) and in this work highlight the specificity of this mAb, which could allow for a low 
number of false-positive results in clinical samples. Of particular importance is the lack of 
detectable cross reactivity with M. Bovis, which is the other Mycobacterial pathogen in cattle.  
Second, SERS, in conjunction with ERLs, is a highly sensitive readout tool. By taking 
advantage of the gold to disulfide linking chemistry, many DSNB reporter molecules are 
easily tethered to a single nanoparticle, amplifying the signal from a single binding event. In 
addition, the DSNB-derived monolayer can tether antibodies and thus form a biospecific 
label. By incorporating these ERLs in our sandwich immunoassay, the MAP concentration is 
quantified by the intensity of the intrinsically strong νs(NO2) of the DSNB-derived 
monolayer, and low-levels of detection are obtained. In addition, the good 
precision/reproducibility in measurements seen in the sonicate immunoassay is partially due 
to recent advances in formation of uniform nanoparticles and preparation of optimized ERLs. 
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Another important feature of our SERS-based assay is its potential for integration into 
diagnostic laboratories. The instrumentation (a fiber-optic based Raman spectrometer) has no 
moving parts, is easy-to-use, and has a small footprint on the laboratory benchtop. In 
addition, breakthroughs in optical filters and detectors have decreased the costs of key 
hardware, with instrument pricing from several manufacturers on the order of $10,000-
$15,000. Moreover, other components of the assay can be readily packaged into a kit that 
includes both pre-made capture substrates and ERLs. Based on this, an assay would be 
performed by capturing the antigen from milk and incubating ERLs in under 24 h, and 
research to extend our assay to fecal samples is in progress.  
In summary, we believe that our assay is well positioned to address many of the 
challenges associated with Johne’s disease detection, especially with respect to speed, 
specificity, and sensitivity. As such, experiments focused on the analysis of samples from 
animals clinically infected with MAP are underway. Ongoing work is also aimed at 
improvements in performance by examining approaches to reduce nonspecific adsorption and 
to further amplify the SERS signal from ERLs (e.g. better scatterers and tailored 
nanoparticles). Finally, the extension of this assay to the detection of whole MAP bacteria is 
detailed in the following companion paper (66).  
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FIGURES 
FIG. 1. Schematic of the preparation and procedure for the SERS readout, sandwich 
immunoassay. 
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FIG. 2. Representative SERS spectra in screening studies using heterogeneous immunoassay 
(vertically offset for clarity) and 13E1 (PBS blank) and 8G2, 12C9 and 13E1 mAbs reacted 
with 1.0×107 heat-killed MAP/ml. Data show 13E1 had the highest νs(NO2) intensity. The 
blank spectrum was comparable to 12C9 and 8G2 spectra. 
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FIG. 3. 13E1 cross reactivity with commonly occurring bacteria in bovine feces. Each 
substrate exposed to 105 MAP/ml, PBS blank, E. coli O157:H7 (108 cells/ml), or Salmonella 
(107 cells/ml). 13E1 did not cross react with E. coli or Salmonella as signals were 
comparable to the PBS blank. 
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FIG. 4. SERS intensity for ERLs binding to MAP after various blocking solutions: (1) 
SuperBlock, (2) StartingBlock, (3) 5% BSA in PBS, (4) 2% dry milk in PBS, (5) Casein 
based blocker, (6) PBS/no blocker with either a PBS blank or 1.0×105 MAP/ml for the 
antigen step. SuperBlock yielded the largest SERS intensity and lowest blank signal. 
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FIG. 5. Spectra and calibration curve for sonicate spiked PBS samples. (A) Spectra 
(vertically offset for clarity) and (B) corresponding calibration curve from SERS 
measurements. Dashed line corresponds to the blank plus three times its standard deviation. 
Best fit line is y=631x-1048, R2=0.98. 
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FIG. 6. Calibration curve for K10 sonicate performed in a milk matrix. Dashed line 
corresponds to the blank plus three times its standard deviation. Best fit line is y=592x-993, 
R2=0.99. 
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A paper to be submitted to Clinical and Vaccine Immunology in companion with Part I 
 
ABSTRACT 
The etiological agent of Johne’s disease is Mycobacterium avium subspecies 
paratuberculosis (MAP). Controlling the spread of this disease, however, is hindered by the 
lack of sensitive, selective, and rapid detection methods for the bacteria in milk and feces. By 
using a recently optimized sandwich immunoassay (B. J. Yakes, R. J. Lipert, J. P. 
Bannantine, M. D. Porter, Clin. Vaccine Immunol., submitted) that incorporates newly 
prepared antibodies for MAP and surface-enhanced Raman scattering (SERS) for sensitive 
readout, a detection limit of ~630 and ~740 MAP/ml is achieved in phosphate buffered saline 
and whole milk samples, respectively, that were spiked with heat-treated MAP. Interestingly, 
these detection limits are much lower than expected based on a simple theoretical model for 
the assay. Efforts to reconcile this discrepancy produce evidence for the shedding of a major 
membrane protein from the heat treated bacilli. We show that the presence of shed protein 
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can be exploited as a mechanism for the design of a highly sensitive assay for MAP, which 
can potentially be applied to a wide range of other cell and virus assays.  
 
INTRODUCTION 
Mycobacterium avium subsp. paratuberculosis (MAP) is responsible for extensive 
losses in dairy production on a global scale (45). MAP is also found in other domestic 
ruminants (e.g., sheep (31, 35), and goats (47, 48)) and wildlife (e.g., deer (20, 32, 33), 
antelope (6, 16), bison (54), and rabbits (4, 5, 27)). Animals that are afflicted with MAP 
progress first from silent infection to a subclinical phase but do not yet show observable 
symptoms. Subtle levels of shedding during this time can, nonetheless, lead to the 
undetectable contamination of a herd. Unfortunately, once the physical symptoms associated 
with the clinical and advanced cellular disease phases (e.g., weight loss and chronic diarrhea) 
become evident, the damage is irreversible. 
To control the spread of this disease, a detection method must be sensitive, rapid, 
field deployable, and cost effective. The assay must also be selective for MAP over other 
bacteria often found in milk and fecal samples from cattle. Currently available methods fall 
short of these combined goals. Specifically, bacteriologic culturing is lengthy (12-16 weeks) 
(25), serological tests lack sufficient sensitivity for detection at subclinical levels (8, 9, 11, 
43, 53), and gamma interferon (23) and nucleic acid probe (10, 17) determinations can be 
limited by low specificity. PCR-based methods may also suffer from false-negatives in 
complex matrices (e.g., milk) (50). In the preceding paper (56), a method for detecting MAP 
sonicate in less than 24 h was designed, optimized, and yielded a limit of detection of ~500 
 
60 
bacilli/ml in a buffer matrix and ~1000 bacilli/ml in a milk matrix. The work herein examines 
the extension of this method to the analysis of samples containing whole MAP cells. 
Surface-enhanced Raman scattering (SERS) has recently been shown to function as a 
sensitive detection method in bioanalytical sciences, especially in the area of chip scale 
assays [e.g., immunoassays (1, 13, 14, 22, 34, 36, 37, 41, 55, 59) and DNA (7, 18, 21)]. The 
basis of SERS lies in the use of a roughened metal surface to amplify normal Raman 
scattering, which is an inelastic scattering of light from vibrational transitions in a molecule 
that undergo a change in polarizability. The observed enhancement in Raman scattering (up 
to 1014 times (30)) is because of two effects: chemical and electromagnetic. The chemical 
component is based on the formation of a charge-transfer state between the metal surface and 
the adsorbed, Raman scattering molecule (51) and is viewed as contributing approximately 
two orders of magnitude to the overall enhancement. 
The remainder of the enhancement is attributed to electromagnetic effects. When light 
is incident on a metal surface, conduction electrons in the metal can collectively oscillate. 
This process, known as surface plasmon resonance, has a wavelength dependence that is 
connected to the nanometeric roughness of metallic surfaces, and the size and shape of 
nanoparticles (28). There is also a significant body of theoretical work (19, 29, 30, 42, 58) 
that has proven invaluable to the fundamental understanding both mechanisms.  
The method introduced in the previous paper (56), and further developed here, 
capitalizes on these theoretical considerations. By using extrinsic Raman labels (ERLs), 
Raman scattering molecules are chemisorbed to SERS active substrates (i.e., gold 
nanoparticle) and thus takes advantage of both chemical and electromagnetic effects. When 
incorporated into a novel SERS-based sandwich immunoassay (Figure 1), high sensitivity 
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can be achieved (e.g., pico- to femtomolar (22) and single binding event (38) detection). In 
this assay format, a biologically active molecule is selectively sandwiched between a metal 
surface and an extrinsic Raman label (ERL) by a capture antibody and a labeling antibody. 
The work herein evaluates this assay platform for the detection of whole MAP bacteria and 
presents a basis for the observed performance. The signal amplification achieved via 
shedding of a surface protein from MAP is also introduced with results indicating potential 
applicability to other pathogens. 
 
MATERIALS AND METHODS 
Bacteria Preparation. MAP, K-10 strain bacteria were cultured at the National 
Animal Disease Center (NADC, Ames, IA) in Middlebrook’s 7H9 medium (Becton 
Dickinson, Cockeysville, MD) that was supplemented with mycobactin J (Allied Monitor 
Inc., Fayette, MO), oleic acid albumin-dextrose complex (Difco, Detroit, MI), and Tween 80 
(Sigma-Aldrich, St. Louis, MO) (56). The bacilli were removed by centrifugation, washed 
with cold phosphate buffered saline solution (PBS; 0.15 M, pH 7.2), and heat treated at 80°C 
for 30 min. Whole cell bacterial concentrations were determined by flow cytometry using 
LIVE/DEAD® BacLight™ Bacterial Viability and Counting Kit (Molecular Probes, Eugene, 
OR). These measurements yielded an average value of 1.3±0.3×107 bacteria/ml. These values 
were further verified by culturing live MAP and serial dilution plating on Herrold’s egg yolk 
slants containing mycobactin J (2 mg/liter).  
Preparation of PBS and Whole Milk Samples. Antigen solutions were prepared at 
room temperature by serial dilution of the MAP stock solution with either PBS (pH 7.4, 10 
mM powder packs, Sigma-Aldrich) or pasteurized, whole milk. Between each dilution, 
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solutions were briefly vortexed to ensure homogeneity. Distilled water, subsequently 
deionized with a Millipore Milli-Q system (18 MΩ, Billerica, MA), was used for the 
preparation of all aqueous reagents. For the milk matrix, the initial dilution was made by 
adding 10 μl of 107 MAP/ml in PBS to 90 μl of whole milk; all further serial dilutions were 
performed from this 106 MAP/ml stock.  
Antibodies. The monoclonal antibody (mAb), labeled 13E1, is specific to the major 
membrane protein MAP2121c (2). The MAP2121c protein was recombinantly produced in 
E. coli and subsequently used to immunize mice for production of mAbs (3). 13E1 was then 
purified from tissue culture supernatants at the Iowa State University Hybridoma Facility 
using Melon Gel (Pierce, Rockford, IL). The 13E1 concentration was determined by 
spectrophotometric measurements at 280 nm (ND-1000, ε=13.7 L g-1 cm-1, NanoDrop, 
Wilmington, DE). All dilutions of 13E1 employed 50 mM borate buffer (pH 8.3 borate 
buffer packs, Pierce). 
ERL Preparation. Previous studies presented a detailed procedure for the formation 
of ERLs (14, 56). Briefly, 1.0 ml of 60-nm gold particles (<8% variation in diameter, 2.6 x 
1010 particles/ml, Ted Pella, Redding, CA) was mixed with 40 µl of 50 mM borate buffer (pH 
8.3). This step was followed by the addition of 10 µl of 1 mM 5,5’-dithiobis (succinimidyl-2-
nitrobenzoate), DSNB, in acetonitrile (HPLC-grade, Fisher, Pittsburgh, PA). DSNB coats the 
nanoparticles as an adlayer of gold-bound thiolate and serves as the Raman scatter and linker 
molecule for antibody attachment. After 7 h of incubation, 20 μg of 13E1 were added and 
reacted for ~12 h, a step which tethers the mAb to the DSNB-derived coating via an amide 
linkage.(15, 26, 52) Finally, 100 μl of 10% bovine serum albumin (BSA, Sigma-Aldrich) in 2 
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mM borate buffer were pipetted into the suspension and reacted for 7 h to block unreacted 
succinimidyl esters.  
For removal of excess reagents, the colloidal suspension was centrifuged (Eppendorf 
MiniSpin, Westbury, NY) at 2,000g for 10 min. The supernatant solution was removed, and 
the loose ERL pellet was resuspended in 1000 µl of 2 mM borate buffer containing 1% BSA. 
This process was repeated twice to maximize removal of unreacted materials, with a final 
resuspension volume of 500 µl. The next step added 50 µl of 10% w/v sodium chloride 
(Sigma-Aldrich) to the suspension in order to mimic biological conditions. Finally, to remove 
any large clusters of nanoparticles, the solution was passed through a 0.22-µm syringe filter 
(Costar, Fisher). 
Capture Surface Formation. The capture substrates were constructed per earlier 
protocols (14, 22, 36, 37, 56). Gold substrates were prepared by resistive evaporation of ~300 
nm of 99.9% pure gold at 0.1 to 0.2 nm/s onto a 4-in. p-type, test grade silicon [111] wafer 
(University Wafer, South Boston, MA) using an Edwards 306A evaporator. Cleaned 1×1 cm 
glass chips were then gently affixed to the gold surface via two-part epoxy (Epo-tek 377, 
Billerica, MA) and cured at 150°C for 1.75 h. Separation of glass chips from the wafer 
exposed the underlying gold surface. The gold chips were then modified by forming a 
hydrophobic barrier that surrounds the assay address. To this end, an octadecanethiol (Sigma-
Aldrich) coated, poly(dimethyl siloxane) (Dow Corning, Midland, MI) stamp, with a 3.2-mm 
diameter centered hole, was used to ink the gold surface. The substrates were then exposed to 
a 1 mM, ethanolic (Aaper, Shelbyville, KY) solution of dithiobis(succinimidyl propionate) 
(DSP, Sigma-Aldrich) for 14 h. After rinsing the substrates with ethanol and drying under a 
stream of high purity nitrogen, 20 µl of 13E1 (100 µg/ml) were pipetted onto the substrate 
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and reacted for 7 h. This step linked the mAb to the substrate by the same mechanism used in 
the ERL preparation. The slides were then rinsed three times with 2 ml of 10 mM PBS buffer. 
Finally, unreacted succinimidyl endgroups were capped with SuperBlock (20 µl drop, 
Pierce).  
Immunoassay Protocol. The capture substrates were exposed to varying 
concentrations of heat-killed, whole cell MAP (referred to hereafter simply as MAP) in 10 
mM PBS buffer (pH 7.4) or pasteurized, whole milk. After incubating at room temperature in 
a humidity chamber for 7 h, the substrates were washed three times with 2 mM borate buffer 
(pH 8.3) with 150 mM NaCl. Next, the captured antigen was labeled with ERLs (20 μl drop) 
through a 14-h incubation step. Finally, the surfaces were rinsed with the borate buffer and 
gently dried with nitrogen. 
SERS Measurements: NanoRaman™ I. SERS spectra for the immunoassay were 
collected using a NanoRaman™ I spectrometer (Concurrent Analytical, Waimanalo, HI) with 
a HeNe laser (632.8 nm, 30 mW output), fiber-optic-based probe head, an f/2.0 Czerny-
Turner imaging spectrometer (6-8 cm-1 resolution), and a 0°C thermoelectrically cooled CCD 
(Kodak 0401E). Normal incidence laser light was focused onto the substrate surface via a 
0.68 numerical aperture objective (25-μm diameter spot, 2-3 mW at surface), and exposure 
times of either 1- or 5-s were employed. The same objective and fiber optic probe collected 
the scattered radiation. All the data points in the resulting calibration curves are the average 
of five measurements at different locations on individual capture substrates. 
SERS Measurements: Raman Microscope. The samples were also examined by 
using an in-house Raman spectroscopy microscope. This system was composed of an optical 
microscope (Olympus BH-2, Centervalley, PA) and spectrograph (SpectraPro, 300i, Acton 
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Research, Acton, MA) that was connected to a thinned, back-illuminated, liquid nitrogen-
cooled CCD (LN/CCD-1100PB, Princeton Instruments, Trenton, NJ). For spectral 
measurements, a 60-mW HeNe laser (632.8 nm) was attenuated through a variable, neutral 
density filter (Thorlabs, Newton, NJ). The substrate was mounted on the microscope sample 
stage, and laser light was focused through a 100×  objective to form a ~1.5-μm diameter spot 
size at an incident power of ~1 mW. The scattered light was collected through the same 
objective and directed to the spectrograph. All the microscopy-based spectra were collected 
with a 2-s integration time via WinSpec/32 (Princeton Instruments), and microscope images 
were obtained with ATI Multimedia video software (ATI Technologies, Markham, Ontario). 
Scanning Electron Microscopy (SEM) Imaging. SEM images were obtained using 
a JEOL 59101v instrument (Tokyo, Japan). Each sample was sputter coated with a thin layer 
of gold prior to loading in the SEM chamber. A working distance of 10 mm and an 
accelerating voltage of 15 kV were used. All the images herein are from secondary electrons. 
 
RESULTS 
Spiked PBS Samples. As noted earlier, MAP solutions in PBS were incubated with 
the capture substrate, exposed to the ERLs, and read out with an integration time of 5 s 
(Figure 1: B1, C1). The overall process was completed in fewer than 24 h. The resulting 
SERS spectra and calibration curve are presented in Figure 2. All the spectral features 
evident in Figure 2a are consistent with vibrational modes for the DSNB-derived monolayer 
that coats the ERLs. The strongest band in the spectra is at 1336 cm-1 and is attributed to a 
symmetric nitro stretch, νs(NO2), whereas the weaker bands at 1062 and 1554 cm-1 are 
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assigned to aromatic ring modes. In accord with Figure 1, the SERS intensities should track 
with the amount of bacteria in the antigen solution, and this trend is observed in Figure 2a. 
To create the calibration curve in Figure 2b, the SERS intensity in each spectrum was 
calculated by subtracting the background at 1225 cm-1 from the signal maximum at 1336 cm-
1 and plotted as a function of MAP concentration. The plot shows the expected increase in 
SERS intensity with an increase in MAP concentration, and a linear dynamic range, 
discussed in more detail later, spans at least five orders of magnitude. The lowest detectable 
signal, defined as the blank signal plus three times its standard deviation, is marked by the 
dashed line on the calibration plot. The intersection of this line with the best-fit to the data 
defines the limit of detection (LOD), which in this assay is ~630 MAP/ml. 
Spiked Whole Milk. To assess performance in more complex matrices, milk was 
spiked with MAP at concentrations ranging from 0 to 5.0×106 MAP/ml. These assays 
followed the same procedure used for PBS but employed a readout time of 1 s. The resulting 
calibration curve is shown in Figure 3. Interestingly, the LOD in the whole milk matrix is 
~740 MAP/ml, which is only slightly larger than that found when using PBS. Moreover, the 
results for PBS (Figure 2) and whole milk (Figure 3), as judged by the best fit lines, y-
intercept, and precision are strikingly similar after taking into account the difference in 
integration times (5 s for spiked PBS and 1 s for spiked milk). These similarities argue that 
the presence of a complex matrix (whole milk) does not compromise the performance of our 
MAP assay. 
MMP Shedding. While the performance of this assay is beginning to meet the 
multifaceted needs for MAP detection, a more in-depth examination of the data (e.g., LOD) 
raises questions as to the origins of the results. As discussed in detail shortly, the theoretical 
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LOD for our SERS-based assay is ~8×105 cells/ml. However, the experimentally determined 
LOD is more than three orders of magnitude lower than this prediction. This discrepancy led 
to investigations to evaluate the signal amplification per cell, with studies emphasizing the 
possibility of protein shedding.  
Two experiments were performed to determine if free MAP2121c protein was present 
in the bacterial solution, which would potentially contribute to response via the pathway 
depicted in Figure 1:B2 and C2. The first experiment carried out assays using MAP-
containing solutions before and after removal of MAP bacilli. The second study used capture 
substrates that had been exposed to solutions containing MAP and subsequently interrogated 
with a Raman microscope. This microscope has a focused laser spot that is comparable in 
size to that of a MAP bacillus, and can therefore be used for characterizations of the SERS 
response in areas with and without bacteria present.  
To these ends, one set of substrates was exposed to MAP-containing solutions (20 
μl). The remaining solutions were then centrifuged at 7,000 rpm (~3,300g) for 10 min to 
pellet out the bacteria. Next, 20 μl of the resulting supernatant were pipetted onto a second 
set of capture substrates. After completing the incubations with the antigenic solutions and 
ERLs, the SERS responses and light microscope images of each sample were obtained. The 
microscope images (data not shown) revealed that: (1) bacteria were bound to the substrates 
exposed to the whole cell MAP solutions, and (2) no bacteria were detectably captured on the 
substrates treated with only the supernatant solution. These results indicate that the 
centrifugation step effectively removes MAP from solution.  
Figure 4 summarizes the data obtained from the assays of the whole cell MAP 
solutions and supernatant from the same solutions after centrifugation. The two data sets plot 
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SERS intensities of the νs(NO2) versus the MAP concentration in the original solutions. The 
two plots, which exhibit an increase in signal with an increase in MAP concentration, are 
virtually indistinguishable. These findings begin to validate our hypothesis of protein 
shedding. In other words, there is major membrane protein (MMP) in the whole cell 
solutions, which can be captured and labeled. Furthermore, the remarkably strong similarity 
of the two plots argues that shed protein is the overwhelming contributor to the observed 
responses for the whole cell solutions. 
 The second experiment further tested the shedding hypothesis by using an in-house 
designed Raman Microscope and the capture substrates exposed to whole cell MAP. With 
this instrument, the capture substrate can be translated under the 1.5-μm laser spot to evaluate 
the signature of a single, captured bacterium or an area of the substrate devoid of bacilli. 
When the laser illuminated a location free of bacteria, the SERS spectra and calibration curve 
in Figure 5 were obtained. The spectra in Figure 5a not only have features characteristic of 
the DSNB-based label, but also undergo intensity changes in-line with the amount of bacteria 
in the antigen solution. This trend is also evident in the calibration curve in Figure 5b. These 
data are another strong indicator for the presence of shed protein on the capture surface 
which, in turn, points to free protein in the whole cell solution. 
When the laser was focused on a single bacterium (Figure 6a), a weak, but distinct, 
spectrum is obtained (Figure 6b). While having a few bands indicative of the Raman reporter 
molecule, the spectrum also has a broad feature at 1600 cm-1, which we believe originates 
from the underlying microorganism (57). Upon characterizing 11 individual bacilli from 
capture substrates exposed to different MAP concentrations, the average intensity for 
νs(NO2) was only 170 ±11 cts/2 s.  
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There are two important conclusions that can be drawn from these results. First, 
captured bacteria appear to generate a SERS response after ERL labeling. Second, the 
response is much smaller than that observed when interrogating locations devoid of bacilli. In 
fact, the signal strength from an intact bacterium is on par with that from the blank spectra in 
Figure 5. These observations are consistent with the overlay of the two plots in Figure 4, and 
are again an indication that any captured whole cell MAP has, at best, a minor contribution to 
the SERS signal.  
Lastly, these samples were imaged by SEM in order to establish the location of the 
ERLs and bacteria on the capture substrate. The samples were therefore briefly rinsed with 
deionized water to remove salt residue, dried, sputter coated with gold, and imaged. Shown 
in Figure 7 are SEM images (~12×9 μm and ~4×3 μm) of a capture substrate that was 
exposed to 1.3×107 MAP/ml. A single bacterium, identified by its rod-like shape (~1×0.5 
μm), is evident in the center of both images. There are also several smaller, circular objects 
that have a size consistent with the 60-nm gold core of the ERLs. However, very few ERLs 
appear close enough to the microorganism to be irradiated by the laser when focused on the 
bacillus. Most of the nanoparticles are comparatively well removed from the bacillus. There 
were, however, very few nonspecifically bound ERLs (~15 in 100 μm2) on blank samples (0 
MAP/ml), and no visible bacteria. These findings further support the likelihood that shed 
protein is captured by the substrate and that the majority of the response for the whole cell 
MAP assay arises from ERLs bound to shed protein and not captured bacteria. 
In summary, studies yield three important conclusions: (1) there is shed protein on the 
assay surface, (2) the amount of protein increases as the original amount of bacteria in the 
solution increases, and (3) captured, shed protein can bind ERLs. The implications of these 
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findings to assay performance and the fundamental detection mechanism are discussed in the 
next section. 
 
DISCUSSION 
 The work herein, which was designed to build on our assay for MAP sonicate from 
the companion paper (56), has demonstrated the apparent ability to quantitate heat-killed, 
whole cell MAP in fewer than 24 hours and at LODs of ~630 MAP/ml in PBS and ~740 
MAP/ml in whole milk. While we need to push performance to higher sensitivity to address 
the need for subclinical levels of detection, this work is our first step towards the creation of 
a platform for direct evaluation of bacteria levels in milk. Our approach has LODs that are 
comparable to that recently obtained (~500 CFU/mL) by Stratmann and coworkers, by 
applying a new peptide-mediated capture PCR method to  artificially contaminated milk (49), 
but our method may potentially be in a more easy-to-use format. 
We noted earlier, however, that the LOD for our MAP assay is a few orders of 
magnitude lower than theoretical expectations. The theoretical detection limit for this assay 
can be approximated by assuming the lowest level of detection corresponds to a single 
bacterium present in the laser spot. Since the surface area of the capture substrate is defined 
by its 3.2-mm diameter, and the laser has a diameter of 25 μm, one bacillus per laser spot 
equals 1.6×104 cells in the assay area. This number of bacteria, when placed in to a 20-µl 
sample droplet, translates to a detection limit of 8.2×105 cells/ml. The projected theoretical 
LOD is therefore over one thousand times greater than the experimentally determined LOD 
of ~700 MAP/ml. It is precisely this issue that triggered the investigations that confirmed the 
presence of the shed MMP targeted by the 13E1 mAb. 
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 The next question rests with the mechanistic origin of shed MMP. Is the protein 
secreted by the bacillus or is shedding induced by sample preparation? Other Mycobacteria, 
specifically M. bovis BCG, are known to release cell wall lipids (40). However, MAP2121c 
has no signal sequence to suggest secretion and has been previously shown to be associated 
with the cell membrane (2). It would nonetheless be invaluable to determine if live 
Mycobacteria shed protein. 
 We believe the observed shedding is caused by sample preparation, with the surface 
protein being stripped from the bacteria by agitation during heat treatment and/or antigen 
solution preparation. In fact, a recent study has shown that surface proteins can be readily 
detached from MAP by brief sonication (44). It is possible that the vortexing step in our 
sample preparation does exactly that. Nonetheless, shedding leads to an effective approach to 
signal amplification from individual cells, and we believe is central to the reported detection 
limits. 
 These results point to an intriguing new strategy to increase the sensitivity and 
specificity of various diagnostic tests by harnessing protein shedding. Since it is likely that 
other MAP proteins are also shed, an approach to enhance the specificity and sensitivity of a 
test for MAP could potentially be devised by the concurrent detection of multiple surface 
proteins. To this end, work to further evaluate the shedding process and extend the concept of 
multiple protein detection is currently underway. In addition, efforts to investigate the 
applicability of the concept to other bacteria as a general mechanism for signal amplification 
are planned.  
Another intriguing aspect of our MAP assay is its large linear dynamic range, which 
is at least five orders of magnitude on the log scale. Simple equilibrium models of two-site 
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immunoassays predict a linearity of only three orders of magnitude in antigen concentration 
(12). As discussed in work by Plowman et al. (39), larger dynamic ranges can arise by the 
existence of two different ligand-receptor interactions, for example, in the capture step. Thus, 
the breadth of the dynamic range would be larger than that typically predicted because the 
stronger interaction would dominate binding at the lower concentrations, followed by capture 
at the sites with the lower binding strength. Indeed, preliminary results that are based on the 
Plowman model for the MMP-13E1 interaction (i.e., one strong and one weak binding 
constant) begin to qualitatively extend the linear dynamic range by another two to three 
orders of magnitude. Work to fully model these findings is ongoing and will be reported 
elsewhere. 
 In conclusion, the performance of our heat-killed, whole cell MAP assay is dominated 
by the presence of shed surface protein. Due in part to this amplification, our assay allows for 
a rapid, selective, and sensitive test that can translate to complex sample matrices and thus 
possibly improve upon current diagnostic tests for Johne’s disease. In addition, the 
quantitative nature of this assay may enable further refinement in definitions of disease 
stages and progression. Finally, studies to detect MAP from fecal samples as well as 
monitoring MAP levels in controlled Johne’s disease herds are in progress. 
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FIGURES 
FIG. 1. Schematic of sandwich immunoassay for MAP bacilli and illustration of shed protein 
assay format. 
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FIG. 2. Spectra and calibration curve for MAP spiked PBS samples. (A) Spectra (vertically 
offset for clarity) with intensity in counts (cts) per 5 s and (B) corresponding calibration 
curve using νs(NO2) intensity. Dashed line corresponds to the blank plus three times its 
standard deviation. Best fit line is y=913x-1568, R2=0.98. 
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FIG. 3. Calibration curve for whole cell MAP in a milk matrix. Same trend as observed in 
FIG. 2  (1 s integration, y=281x-395, R2=0.95) with increasing SERS intensity with 
increasing MAP in the antigen solution. Dashed line corresponds to the blank plus three 
times its standard deviation. 
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FIG. 4. SERS intensity of whole cell MAP solutions compared to supernatant of these 
solutions after bacteria have been pelleted out. The points from the two assays, whole cell 
MAP and supernatant without MAP, coincide. Dashed line corresponds to the blank plus 
three times its standard deviation. 
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FIG. 5. (A) Spectra vertically offset for clarity and (B) corresponding calibration curve from 
Raman microscope measurements of areas between bacteria on the assay substrate. Signals 
from areas devoid of bacteria increased with increased MAP in the antigen solution 
indicating that ERLs were specifically bound to the substrate surface. Dashed line 
corresponds to the blank plus three times its standard deviation. 
 
 
 
 
 
Log (MAP/ml)
2.0 3.0 4.0 5.0 6.0 7.0
In
te
ns
ity
 a
t 1
33
6 
cm
-1
 (c
ts
/2
 s
)
100
200
300
400
500
600
700
800
Raman Shift (cm-1)
800 1000 1200 1400 1600
400 cts/2 s
0  
 
103   
 
105  
 
107  
MAP/ml 
(A)
(B)
 
83 
FIG. 6. (A) Laser spot from 100× objective over a single bacterium and (B) SERS spectrum 
from the single bacterium with bound ERLs obtained with the Raman microscope. The 
bacterium had a SERS spectrum containing the distinct spectra features of the DSNB-derived 
Raman reporter indicating that ERLs were also bound to the bacteria. 
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FIG. 7. SEM images of an assay platform exposed to 1.3×107 MAP/mL and 60-nm ERLs 
with (A) bacterium in the center and (B) and expanded area from box in (A).  Results 
visually confirm spectroscopy measurements in FIG. 5 and 6. 
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ABSTRACT 
Assays based on surface-enhanced Raman scattering (SERS) as a readout tool have 
recently begun to incorporate the resonance Raman effect. By integrating this concept of 
surface-enhanced resonance Raman scattering (SERRS) into a heterogeneous immunoassay 
platform, stronger signals can be realized that may also lead to lower levels of detection. This 
paper therefore focuses on incorporating organic dyes as reporter molecules that are tethered 
to 60-nm colloidal gold which is also coated with antibodies. When performing assay 
comparisons, resonant molecules (i.e., Alexa Fluor 647, 5-(and-6)-
carboxynaphthofluorescein, and Cy5, and malachite green isothiocyanate) yield signal 
enhancements of ~100 to 350 times compared to the nonresonant 5, 5’-dithiobis 
(succinimidyl-2-nitrobenzoate), which is used as a reference. This paper details the 
development of stable colloidal gold suspensions through the optimization of labeling 
reactions and pH, presents SERRS spectra for four resonant dyes, and examines the 
immunoassay performance with respect to detection limits and nonspecific adsorption. 
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INTRODUCTION 
 The importance of biomolecule detection is undergoing a nearly explosive growth in 
clinical, environmental, agricultural, and defense arenas.[1] The motivation behind this 
emerging emphasis reflects, in part, the role of rapid, cost-effective, sensitive, and selective 
immunoassays as applied to early disease detection and homeland security. One detection 
technique that has attributes in tune with these needs is surface-enhanced Raman scattering 
(SERS). In SERS, incident electromagnetic radiation couples with the surface plasmon 
oscillation of a roughened metal surface and an adsorbed Raman active molecule. SERS was 
first observed in 1974 by Fleischmann and coworkers,[2] but not fully recognized until 1977 
by Jeamarie and Van Duyne[3] and by Albrecht and Creighton.[4] SERS relies on a 
combination of chemical[5-7] and electromagnetic[8-10] enhancement effects that combine 
to yield signals up to 1014 times larger than normal Raman scattering.[11] 
SERS as a readout tool for immunoassays has several notable attributes that make it a 
potentially attractive alternative to traditional techniques such as colorimetry, radioisotope 
decay, and fluorescence.[8,12,13] First, SERS intensities have been shown to rival that of 
fluorescence while having much narrower bands. This advantage allows for sensitive 
(pico/femtomolar)[14] biolyte detection while enabling multiplexed detection[13] due to less 
spectral overlap. In addition, Raman scattering is a versatile technique that has minimal 
fluorophore photobleaching, since the excitation state has an extremely short lifetime. This 
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excitation wavelength is substrate but not scattering molecule dependent, so a single 
excitation source can be used.[15] Finally, SERS is a robust readout method that is 
unaffected by the surrounding environment (e.g., quenchers, pH, ionic strength) which then 
allows for a more reproducible signal intensity. 
In an attempt to obtain stronger SERS signals and, by extension, possibly even higher 
sensitivities, approaches based on surface-enhanced resonant Raman scattering (SERRS) 
have begun to appear.[16-25] This phenomenon occurs when an immobilized Raman active 
molecule has an electronic transition that is in resonance with the excitation photon. This 
condition leads to the higher adsorption of the incident energy, a larger probability for 
scattering, and, therefore, larger signal intensities.[26]  
 Based on these attributes, SERRS has begun to gain popularity as a readout method in 
immunoassays and gene detection assays. Mirkin and colleagues[17,18,25] have prepared 
silver coated-gold nanoparticle probes that contain a Raman dye for SERRS detection of 
oligonucleotides and proteins. By selectively tagging DNA with a SERRS active molecule, 
Vo-Dinh and coworkers[19] have performed gene diagnostics through hybridization of the 
probes to complementary DNA-coated, silver chips. Graham and coworkers have reported 
the SERS-based detection of tagged PCR products[23] and dye-labeled oligonucleotides via 
silver nanoparticles.[21] In conjunction with that work, they have also developed 
benzotriazole dye-silver nanoparticle conjugation chemistry.[22] Advances in colloidal 
stability have been achieved by Natan and colleagues[24] through glass-coated, reporter 
encased, metal nanoparticles that are then used in bioassays. Furthermore, Nie and coworkers 
[16,20] have also used a silica shell – dye embedded, nanoparticle core approach for 
detection of cancer markers. 
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While demonstrating the strengths of using SERRS, many of the above methods do 
not optimally position the dye on the enhancing substrate. Minimizing the distance between 
the SERS surface and the reporter is essential because the electromagnetic SERS 
enhancement decays rapidly with respect to the distance, d, from the substrate (i.e., d-10 or d-
12)[9,27]. Furthermore, when the dye is directly adsorbed on the nanoparticle, methods to 
stabilize the colloid against aggregation (i.e. silica encapsulation) are necessary. This paper 
seeks to address both challenges through investigating covalently attached dye molecules on 
a gold surface in an attempt to increase SERRS signals without any post-formation 
stabilization steps. These stabilized labels will then be incorporated into an immunoassay in 
order to determine the enhancement achieved. 
As part of our interests in this area, we have used variants of the platform shown in 
Figure 1 for the detection of small proteins[13,28], cancer markers[14], viruses[29,30], 
bacteria[31-33], and spores[33]. For the work herein, the two site, heterogeneous 
immunoassay begins, as shown, by coupling mouse-IgG antibody to the adsorbed thiolate of 
dithiobis(succinimidyl propionate) (DSP) through succinimidyl ester chemistry. When the 
respective antigen is present, the capture substrate will selectively extract mouse-IgG from 
solution. After a rinse step, the substrate is exposed to a solution of extrinsic Raman labels 
(ERLs) which selectively label the captured antigen. In this case, the ERLs are formed by 
adsorbing anti-mouse IgG to a portion of the gold nanoparitcle surface and then coating the 
remaining gold surface with the Raman reporter molecule. 
As few studies have focused on comparing SERRS immunoassays with their 
nonresonant counterpart via changing only the molecular label, four commercially available 
organic dyes that have excitation maxima near resonance with the HeNe laser wavelength 
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(632.8 nm) will be compared with our well-characterized, nonresonant label 5,5’-dithiobis 
(succinimidyl-2-nitrobenzoate) (DSNB). The resonant molecules, given in Table 1, were 
chosen to represent the diversity of commercially available dyes. As such, multiple 
functional groups (i.e., succinimidyl ester or isothiocyanate) and charge states (i.e., net 
positive or negative charge) were tested. This work details the development of stable 
resonant dye ERLs without the need for post-formation modification procedures, integrates 
the four resonant and one nonresonant (DSNB) label into an immunoassay, and evaluates the 
performance of the resonant ERLs versus the DSNB ERLs. 
 
EXPERIMENTAL 
2.1. Chemicals and Reagents  
Colloidal, 60-nm gold nanoparticles (2.6 x 1010 particles/mL, <8% variation in 
diameter), were purchased from Ted Pella (Redding, CA). ImmunoPure® mouse IgG and 
ImmunoPure® Goat anti-mouse IgG (minimum cross reactivity with human, bovine, and 
horse serum proteins) were obtained from Pierce Biotechnology (Rockford, IL). Porcine 
parvovirus (PPV, 6.4 × 106 TCID50/10 mL of 10 mM PBS) and PPV antibody (~1.4 mg/mL 
in 50 mM borate buffer) were provided by the National Animal Disease Center (Ames, IA). 
Bovine serum albumin (BSA), 2-aminoethanethiol (AET), octadecanethiol (ODT), 
dithiobis(succinimidyl propionate) (DSP), and sodium chloride were procured from Sigma-
Aldrich (St. Louis, MO). 
For preparation of template stripped gold (TSG), silicon wafers (4-in, p-type, [111] 
test grade wafer) were obtained from University Wafer (South Boston, MA), Epo-tek 377 
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part A and B epoxy was supplied by Epo-tek (Billerica, MA), and poly(dimethylsiloxane) 
(PDMS) was purchased from Dow Corning (Midland, MI). 
The nonresonant Raman label (DSNB) was synthesized according to our previous 
procedure.[14] Resonant Raman dyes were purchased from Molecular Probes (malachite 
green isothiocyanate (M689), Alexa Fluor® 647 carboxylic acid, succinimidyl ester (AF647), 
and 5-(and-6)-carboxynaphthofluorescein, succinimidyl ester (CNF); Carlsbad, CA) or 
Amersham Biosciences (Cy5 Mono NHS ester (Cy5); Piscataway, NJ).  
Distilled water, subsequently deionized with a Millipore Milli-Q system (18 MΩ, 
Billerica, MA), was used for the preparation of all aqueous reagents and buffers. Ethanol was 
acquired from Aaper (Shelbyville, KY). Acetonitrile was procured from Fisher (Pittsburgh, 
PA). Borate buffer powder packs (50 mM, pH 8.3) were purchased from Pierce while 
phosphate buffered saline powder packs (PBS, 10 mM, pH 7.4) were obtained from Sigma-
Aldrich; both were diluted as needed. SuperBlock was obtained from Pierce. 
Buffers were prepared according to standard protocol with PBS used for pH 7-7.5, 
borate buffer for pH 8-9, sodium tetraborate decahydrate (certified ACS, Fisher) buffer for 
pH 9.5-10, and sodium carbonate (Fisher) buffer for pH 10.5-11. An Orion model 520A pH 
meter (Boston, MA), calibrated with pH 7.00 and 10.00 standards, was used for all 
measurements with slight pH adjustments made by addition of aqueous sodium hydroxide 
(certified ACS, Fisher) or sulfuric acid (ACS grade, EMD Chemicals, Gibbstown, NJ). 
 
2.2. Thiol Modification of the Dyes  
To direct the immobilization of the dyes to the gold nanoparticles, AET was used to 
convert the succinimidyl ester terminated compounds (Cy5, AF647, CNF) or isothiocyanate 
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molecules (M689) to thiols or thioureas, respectively, as shown in Figure 2.[34] For these 
reactions, Cy5 was dissolved in water while all other dyes used DMSO; the resulting 
concentrations spanned 0.2 to 1 mM. AET was selected as the tethering molecule since its 
two-carbon chain minimizes the gap between the surface of the gold nanoparticle and label. 
For these reactions, one mole of dye was mixed with 0.9 moles of AET for ~90 min. Once 
prepared, the thiol-modified dye solutions were stored in the dark at 4°C and could be used 
for six months with no observable decrease in Raman signal. We note that the slight excess 
dye molecules proved important, as the presence of unreacted AET destabilized the 
nanoparticle suspension.  
 
2.3. Extrinsic Raman Label (ERL) Preparation 
Labeling procedures to determine optimum conditions for nanoparticle stability were 
studied, and the outcomes of the investigations are presented in the Results section. Briefly, 
the six labeling methods tested are summarized in Table 2. All nanoparticle solutions 
consisted of 500 μL of 60-nm colloidal gold mixed with 20 μL of 50 mM borate buffer. The 
AF647 and AF647-AET solutions had a final concentration of 0.2 mM in DMSO. Method 1 
is our standard ERL preparation in which the nanoparticles were reacted with 5 μL of DSNB 
(8 h incubation) followed by 10 μL of Ab (14 h incubation). Method 2 consisted of: (1) 3.5 
μL of 1 mg/mL AF647 in DMSO reacting with 50 μL of PPV Ab in borate buffer for 1 h; 
and (2) adding 10 μL of the antibody-AF647 solution to the suspension. Methods 3 and 4 
started by absorbing 10 μL of Ab to the nanoparticles (8 h) and were followed by reacting 
either 5 μL of AF647 or 5 μL of AET-coupled AF647 for 14 h. Methods 5 and 6 reversed 
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Methods 3 and 4 by incubating AF647 or AF647-AET for 8 h and then adding antibody (14 
h).  
From this and other studies discussed in more detail in the Results section, an 
optimum labeling procedure was determined to consist of first adding 1 mL of 60-nm 
particles to a centrifuge vial and buffering the solution with 40 μL of 50 mM borate buffer 
(pH 8.3) or 200 μL of 10 mM sodium borate buffer (pH 9.5). To this solution, 11.1 µL of 
anti-mouse IgG (1.8 mg/mL) were added and incubated for 7 h. After adsorbing the antibody, 
20 μL of 1 mM reporter solution (DSNB in acetonitrile; Cy5-AET in water; or AF647-AET, 
CNF-AET, M689-AET in DMSO) were reacted for ~14 h. This process formed a gold-bound 
thiolate between the nanoparticles and Raman scatterers. Finally, 100 μL of a 10% BSA in 2 
mM borate buffer were added to the solution in order to minimize nonspecific binding.  
In order to remove excess, reagents, the mixture was first centrifuged at 2,000g for 10 
min (Eppendorf MiniSpin, Westbury, NY). Next, the supernatant solution was removed, and 
the loose ERL pellet was resuspended in 1000 µL of 2 mM borate buffer with 1% BSA. This 
process was repeated three times with the final resuspension in 500 µL. Finally, 50 µL of 
10% NaCl were added to the colloidal suspension to match biological conditions, and the 
solution was filtered through a 0.22-µm syringe filter (Costar, Fisher) in order to remove 
large clusters of nanoparticles.  
 
2.4. Capture Substrate Preparation 
The substrate platform and immunoassay protocol have been reported 
previously.[13,14,29,33] Briefly, gold templates were prepared by resistively evaporating 
99.9% pure gold (~300 nm, 0.1 to 0.2 nm/s rate) onto a silicon wafer using an Edwards 306A 
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evaporator (Wilmington, MA). Clean 1×1 cm glass slides were affixed to the gold surface by 
Epo-tek 377 part A and B epoxy and cured at 150°C for 1.75 h. The resulting template 
stripped gold (TSG) slides were then gently removed from the wafer. The freshly exposed 
TSG surface was then stamped with an ODT-soaked PDMS stamp that contained a 3.2-mm 
diameter centered hole. This process forms a hydrophobic barrier surrounding the 3.2-mm 
assay area. TSG was then exposed to 1 mM, ethanolic DSP for 14 h and subsequently to 20 
μL of anti-mouse IgG (100 μg/mL, 7 h) thus forming an amide linkage through the 
succinimidyl esters of the DSP and primary amines on the antibody. The substrates were then 
rinsed with 2 mL of 10 mM PBS buffer, and the unreacted succinimidyl endgroups of the 
DSP-derived monolayer were blocked with SuperBlock overnight. 
 
2.5. Immunoassay Procedure 
Capture substrates were exposed to varying concentrations of mouse IgG in 10 mM 
PBS buffer (pH 7.4) for 6 h (room temperature) in a humidity chamber. After rinsing three 
times with 2 mM borate buffer (pH 8.3) with 150 mM NaCl, the ERLs were added and 
allowed to react ~14 h. Finally, the substrates were rinsed with the same borate buffer and 
gently dried under a stream of nitrogen.  
 
2.6. UV-Vis Spectroscopy 
UV-Visible transmission spectra of nanoparticle solutions were collected using a 
Hewlett-Packard model 8435 spectrophotometer. The pathlength of the quartz cuvette was 
1.0 cm. The sample cell was rinsed twice with deionized water and dried between 
measurements. The reference solution consisted of 2 mM borate buffer and 1% BSA. 
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2.7. Zeta Potential Measurements 
A Malvern ZetaSizer Nano Z (Southboro, MA) was used to correlate the zeta 
potential of the ERLs and colloidal stability. The instrument was calibrated with the Malvern 
Zeta transfer solution, and the -46.1 mV result was within the accepted -50±5 mV range. 
ERLs were prepared following the standard procedure, including centrifugation and 
resuspension, but without salt addition and filtration. Three replicate measurements at 25°C 
were performed in all cases. Between samples, the cell was rinsed five times with deionized 
water (5 mL per wash). By measuring the electrophoretic mobility of the particles, the zeta 
potential can be calculated by the Henry equation and the Smoluchowski approximation.[35] 
 
2.8. SERS Instrument 
SERS spectra for the immunoassay were collected using a NanoRamanTMI 
(Concurrent Analytical, Waimanalo, HI). This instrument consists of a HeNe laser (632.8 
nm, 30 mW, 491 µm2 spot size), fiber-optic-based probe head, thermoelectrically cooled 
CCD (Kodak 0401 E, 0°C), and an f/2.0 Czerny-Turner imaging spectrometer (6-8 cm-1 
resolution). Normal incident laser light was focused onto the substrate surface with a 0.68 
numerical objective that also collected the scattered radiation. Exposure times were 1-s for 
DSNB and 0.2-s for the dye-labeled nanoparticles, and spectral data were evaluated with the 
TRCommander 1.3.0 software. Spectra were baseline corrected with Omnic 6.2 (Thermo 
Electron Corporation) software to remove the continuum underneath Raman lines.[36] 
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RESULTS AND DISCUSSION 
3.1. Preparation of ERLs 
The Raman reporter molecule, DSNB, was used to prepare ERLs that served as a 
comparative standard. This nonresonant molecule chemisorbs to the gold surface through 
cleavage of the disulfide bond and subsequent formation of a gold-bound thiolate. Since the 
dye reporter molecules do not have a functional group for direct binding to the gold surface, 
methods to allow both the Abs and the reporter molecule to adsorb to the nanoparticles were 
investigated. In addition, the order of adding Abs and reporter molecules was investigated to 
determine the optimum ERL formation procedure with respect to stability and SERS signal 
intensity. 
Six labeling methods were compared and are outlined in Table 2. For these studies, 
PPV antibody and PPV (a nonenveloped, 25-nm virus) were used in place of anti-mouse and 
mouse IgG, but the immunoassay protocol remained the same. This study asked three 
fundamental questions: (1) Is it possible to label the antibody with the dye molecule prior to 
being added to the nanoparticles (Method 2) and obtain a SERS signal, (2) Does the dye have 
to be preconjugated with AET in order to react with the nanoparticles (Method 3 compared 
with Method 4 (i.e. Methods 3/4) and Methods 5/6), and (3) What order of addition of Ab 
and dye yields stable ERLs and large SERS signals (Methods 3/5 and Methods 4/6)? Method 
1 represents the DSNB labeled nanoparticles as a standard solution.  
Following Steps 1 and 2, BSA blocking, centrifugation/resuspension, and NaCl 
additions were all performed, and the UV-Vis spectra of the ERL solutions were recorded. 
All ERLs, except for Method 5, were red in color and had a single UV-Vis band at ~538 nm. 
These characteristics indicate that the nanoparticles were not detectably aggregated. 
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However, the ERLs from Method 5 (AF647 and then Ab) were aggregated as indicated by the 
purple color, and the presence of two UV-Vis bands (528 and 575 nm). These data indicate 
that if the dye is added in Step 1, it must first be reacted with the AET in order to avoid 
particle instability. 
The stable nanoparticles were then filtered and used in an immunoassay with PPV 
(6.4 × 106 TCID50/mL). Each SERS spectra were evaluated to determine if bands 
characteristic of the reporter were visible. As expected, the DSNB standard ERLs yielded 
bands attributable to the reporter molecule, as will be discussed later.[29] In addition, the 
particles modified by Methods 4 and 6 have bands representative of AF647, whereas those 
derived by Methods 2 and 3 had no visible bands. These results indicate that: (1) labeling the 
antibody prior to addition to nanoparticles does not yield a SERS signal; and (2) when 
AF647 was not coupled to AET, no SERS spectrum was observed. These results can be 
attributed to the SERS scatterer being too removed from the nanoparticle for the former and 
the dye molecule not adhering to the nanoparticle in the latter. Furthermore, the ERLs formed 
by Method 4 (Ab then AF647-AET) had larger SERS signals and were more stable over time 
than those formed by Method 6 (AF647-AET then Ab) 
In conclusion, stable ERLs can be formed when antibody is first adsorbed to the 
colloidal gold surface through ionic and hydrophobic interactions and then thiol terminated 
dye (AF647-AET) is chemisorbed to the gold nanoparticle surface. As a result, the following 
experiments used particles modified by Method 4. 
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3.2. Stabilization of ERLs Coated with Positively Charged Dyes 
As previously demonstrated,[37] gold nanoparticles formed by citrate reduction have 
a net negative surface charge which plays a key role in colloidal stability. Upon applying 
Method 4 and using the positively charged M689-AET molecule, the nanoparticles 
aggregated. This observation can be attributed to the adsorbed cations disrupting the stability 
of the suspension as the repulsive, negative interparticle interactions were reduced. This 
description can be theoretically predicted by the Derjaguin-Landau-Vervey-Overbeek 
(DLVO) theory.[38,39] This aggregation has previously been evaluated with positively 
charged indolenine cyanine dyes.[40] Specifically, when these cationic molecules reacted 
with negatively charged gold nanoparticles, electrostatic dye-particle interactions occurred 
and J-aggregated bridged assemblies formed due to π-π interactions. These interactions may 
also be occurring with M689-AET. In order to possibly counteract the positive charge of the 
dye and decrease aggregation, the nanoparticle solutions were made more basic with buffers.  
As such, nanoparticles were conjugated with anti-mouse IgG and buffered to the 
desired pH (7-7.5 with 200 μL of 10 mM PBS, 8-9 with 20 μL of 50 mM borate buffer, 9.5-
10 with 200 μL of 10 mM borate buffer, and 10.5-11 with 20 μL of 50 mM carbonate buffer). 
Following Method 2, M689-AET was then reacted for 5 h. Finally, UV-Vis spectra of the 
solutions were obtained, and the results are shown in Figure 3. As previously 
demonstrated,[29,41,42] a single band at ~535 nm is indicative of a colloidal solution 
composed of isolated 60-nm gold particles, while band broadening or splitting as well as 
shifting to longer wavelengths is diagnostic of aggregate formation. At pH 7.5, the band is 
split. Upon buffering at pH 10.5, a single feature at ~535 nm is obtained. At pH 9, an 
intermediate spectrum is obtained with features indicative of particle aggregation. These 
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results, as well as the spectra from the other pH values tested, indicated that a stable 
nanoparticle suspension is achieved with positive dyes when the pH≥9.5. Because high pH 
values can denature antibodies and lower their binding affinity[43] as well as decrease the 
number of IgG molecules adsorbed to the gold surface,[44] the lowest pH that allowed for 
stable nanoparticles (pH 9.5) was chosen for the remainding studies involving M689-AET 
ERLs. 
The ERLs were also characterized by zeta potential measurements. The zeta potential, 
which is the potential at the slipping plane of a particle, can be used to determine the charge 
of the particles as well as the stability of the colloidal suspension. Upon taking measurements 
with each type of ERL, the data in Figure 4 were obtained. These data indicate that the ERLs 
are all negatively charged and at a comparable magnitude. From this, we speculate that the 
ERLs charge is dominated by the antibody coated nanoparticles and are stable as the pH is 
above the antibody pI (6.6-7.2, [45]). 
 
3.3. Mouse-IgG Immunoassay Spectra and Calibration Curves 
Immunoassays were first performed with the nonresonant DSNB as a label to obtain a 
comparative performance metric. The results of the heterogeneous, two-site immunoassay for 
mouse IgG concentrations ranging from 0.01 to 1000 ng/mL are shown in Figure 5. As 
evident, the representative SERS spectra in Figure 5a, which were obtained at 1-s integration 
times, have characteristics of the DSNB-derived monolayer. The strongest band in each 
spectrum (1336 cm-1) is attributed to a symmetric nitro stretch (νs (NO2)), while the less 
intense feature (1588 cm-1) is associated with an aromatic ring mode. In addition, other 
features are indicative of the DSNB-modified ERLs including a nitro scissoring vibration at 
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851 cm-1 and a succinimidyl N-C-O stretch overlapping with an aromatic ring mode at ~1075 
cm-1.[14] Moreover, as the amount of antigen in solution increases, the intensity of all 
spectral features also increase, demonstrating a corresponding increase in the number of 
ERLs bound to the surface. By plotting the intensity of νs (NO2) versus the log of the antigen 
concentration, the calibration curve in Figure 5b is obtained. As expected, this curve has the 
characteristic shape and approximately three orders of linear magnitude associated with 
equilibrium models of a two-site assay.[43] 
After performing the DSNB ERL immunoassay, the dye-AET ERLs were tested using 
the same assay platform. The SERS spectra for each reporter molecule, taken at 0.1 ng/mL 
mouse IgG and baseline corrected, are shown in Figure 6a. Each reporter has a distinct 
Raman spectral signature, but Cy5 and AF647 have comparable features which can be 
attributed to the similarity of these fluorophores. While the spectra taken of the dye molecule 
ERLs used an integration time of 0.2 s, spectral features for the nonresonant DSNB ERL are 
comparatively weaker even though collected at an exposure time of 1-s, indicating that 
indeed the resonant labels are stronger SERS scatters. 
Upon plotting the intensity for the bands labeled by stars in Figure 6a versus the log 
of the antigen solution concentration, the calibrations curves in Figure 6b are obtained. These 
bands are chosen because of their high SERS intensity and lack of overlapping bands. In this 
format, SERS spectra were normalized to 1-s integration times, and it is clear that the signals 
for the dye molecules far surpass those of the nonresonant DSNB at each antigen 
concentration. In addition, the dye molecule assays qualitatively follow the characteristic 
concentration-dependent signal with larger SERS intensities from higher mouse IgG 
concentrations. 
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3.4. Enhancement of Resonant Raman Labels Over Nonresonant DSNB 
In order to more fully investigate the performance of the resonant molecules, 
enhancement factors and limits of detection were determined. To evaluate the enhancement 
factor, the calibration curves for the dye molecules versus DSNB were compared. Through 
plotting intensity versus the antigen solution concentration, a calibration curve can be 
obtained and a linear trend established. An example of this is shown in Figure 7a for DSNB 
and Figure 7b for Cy5. By comparing the slopes of the best-fit lines between 0.01 ng/mL and 
0.1 ng/mL, relative enhancement factors can be determined. In this example, the slope of the 
Cy5-AET coated ERL is just over 300 times greater than that for the DSNB modified ERL.  
The limit of detection (LOD) is the lowest antigen concentration expected to produce 
a SERS signal distinct from the blank. The dashed line in each curve represents this signal 
and is calculated from the signal of blank plus three times the standard deviation in the blank 
signal. From this, the LOD can be determined from the intersection of the best-fit line with 
the dashed line in each calibration curve. Numerically, the intersection is at 46 pg/mL for 
DSNB and 24 pg/mL for Cy5, which corresponds to approximately 200 fM of mouse IgG. 
The results of this analysis for all the ERLs are summarized in Table 3. Each resonant 
reporter yields an enhanced SERS signal that is approximately two orders of magnitude over 
that of DSNB. The limit of detection, however, is not significantly improved for the resonant 
dyes. At a first pass, one can speculate that if a signal is two orders of magnitude higher, then 
the LOD of would be one hundred times improved if the blank signal for each system was of 
the same magnitude and standard deviation. However, the improvement in signal strength 
also applies to the ERLs that are present in the blank from nonspecific adsorption. Thus, 
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while the Cy5-AET ERL has 300 times the signal of the DSNB ERL, the blank is also 300 
times stronger.  
From this, it can be concluded that while resonant molecules do yield much stronger 
signals, the LODs are dominated not by reporter signal strength but by nonspecific 
adsorption. In order to take advantage of the enhanced signals resonant labels offer, 
nonspecific adsorption must be minimized to the point where the blank signal is truly blank 
and dominated only by instrument noise and sample variability. 
 
CONCLUSIONS 
 Increased signal intensities during detection hold promise for creating more sensitive 
assays. In SERS-readout assays, one technique to improve signals is to achieve resonant 
conditions with the Raman active molecule. In our system, ERLs can be used to integrate dye 
molecules that have an adsorption band in tune with the laser wavelength (~633 nm). By 
adapting current methods for forming ERLs, specifically conjugation order and solution pH, 
stable and nonaggregated SERS labels can be obtained for both positive and negatively 
charged resonant dye molecules. The resonant labeled ERLs behaved similarly to the 
standard DSNB reporter as indicated by the calibration curves. In addition, enhancement 
factors for the resonant molecules were determined to be on the order of two magnitudes 
over the nonresonant DSNB, but limits of detection did not show the same improvements due 
to nonspecific adsorption. Studies to improve upon current protocols with respect to 
nonspecific binding are currently underway in order fully realize the potential of the resonant 
molecule labeled ERLs. 
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FIGURES 
Fig. 1. Formation of ERLs and heterogeneous immunoassay procedure. 
 
Table 1. Reporter names, acronyms, spectral characteristics, and molecular charges. 
 
Fig. 2. Reactive endgroup formation. 
 
Table 2. ERL labeling strategies. 
 
Fig. 3. ERL stabilization: UV-Vis spectra of ERLs, containing α-mouse IgG and M689-AET, 
buffered to varying pH values. 
 
Fig. 4. Zeta potential measurements of ERLs showing similar charges and stability for each 
nanoparticle/dye-AET combination. 
 
Fig. 5. Mouse IgG immunoassay with DSNB reporter: (a) spectra for individual antigen 
concentrations (1-s integration, offset for visual clarity) and (b) corresponding calibration 
curve with each data point an average of five measurements per slide. 
 
Fig. 6. Mouse IgG immunoassay for all reporters: (a) representative spectra for each reporter 
at an antigen concentration of 0.1 ng/mL, integration times as listed (offset and baseline 
corrected for visual clarity) and (b) corresponding calibration curves for low concentration 
antigen solutions. All dye molecules were in the dye-AET reacted form. 
 
Fig. 7. Calibration curve for mouse IgG immunoassay, lower concentration ranges for (a) 
DSNB and (b) Cy5-AET form. Average of five measurements per slide and dashed lines 
indicating the level of detection based on blank + 3σ of blank. 
 
Table 3. Enhancement (normalized to DSNB) and limit of detection (LOD, pg/mL) as 
determined from the intersection of the slope of the best-fit line (between 0.01 and 0.1 
ng/mL) and the (blank+3σ) level for each reporter tested. All dye molecules were in the dye-
AET reacted form. 
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Fig. 1. 
 
 
 
(A) Preparation of Extrinsic Raman Labels (ERLs)
Raman 
ReporterAnti-IgG60-nm gold
Mouse IgG
(7 h)
Anti-IgG ERLs     
(14 h)
(B) Sandwich Immunoassay Procedure
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Table 1. 
 
Negative2672602CNF5-(and 6-) carboxynaphthofluorescein, SE
PositiveNone629M689Malachite green isothiocyanate
1665650AF647Alexa Fluor 647 SE
Negative664646Cy5Cy5 monofunctional, succinimidyl ester 
(SE)
Neutral400320DSNBDithiobis (succinimidyl nitrobenzoate)
ChargeEm Max 
(nm)
Ex Max 
(nm)
Abbrev.Molecule Name
1 No structure available for Alexa Fluor
2 CNF has a pKa of 7.6  
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Fig. 2. 
 
(A) Succinimidyl Ester Reaction
(B) Isothiocyanate Reaction
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Table 2. 
 
 
 
 
 
1 nanoparticle solutions (nps)
Add AbReact nps with AF647-AET6
Add AbReact nps with AF6475
Add AF647-AETAdsorb Ab to nps4
Add AF647Adsorb Ab to nps3
Add 10 µL of Step 1 to npsReact Ab with AF6472
Add AbReact nps1 with DSNB1
Step 2Step 1Method
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Fig. 3. 
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Fig. 4. 
 
 
 
Raman Reporters
DSNB Cy5 AF647 M689 CNF
Ze
ta
 P
ot
en
tia
l (
m
V,
 N
 =
3)
-25
-20
-15
-10
-5
0
 
111 
Fig. 5. 
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Fig. 6. 
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Fig. 7. 
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Table 3. 
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ABSTRACT 
Electrochemically modulated liquid chromatography (EMLC) manipulates analyte 
retention by changing the potential applied (Eapp) to a conductive stationary phase. This paper 
applies EMLC to the separation of triazines, a commonly used, but environmentally 
hazardous, class of herbicides. Experiments herein examine the influence of mobile phase pH 
on retention, in combination with tuning Eapp, to take advantage of the ionizablity of the 
triazine ring nitrogen. Results discussed include: (1) the merits of using EMLC to separate 
this class of compounds; (2) the retention mechanism for triazines of dissimilar acid 
strengths; and (3) the rapid separation of a seven-component triazine mixture. 
 
Keywords: electrochemically modulated liquid chromatography; potential control; 
herbicides; triazines; pH 
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INTRODUCTION 
Electrochemically modulated liquid chromatography (EMLC) combines liquid 
chromatography and electrochemistry as a unique approach to manipulate retention. In 
EMLC, a three-electrode electrochemical cell is reconfigured to simultaneously function as 
an HPLC column (Figure 1). In most cases, EMLC columns are packed with porous graphitic 
carbon (PGC) which serves both as a conductive stationary phase and as a working electrode. 
As a result, retention can be fine tuned by changes in the potential applied (Eapp) to the 
column, adding another dimension to LC separations. 
 Several laboratories,[1-11] including our own,[12-27] have investigated a wide range 
of separations with EMLC. To date, EMLC has been applied to the separation of aromatic 
sulfonates,[13] monosubstituted benzenes,[17] pyridines/anilines,[20] corticosteroids,[14] 
benzodiazepines,[15,18] optical isomers,[19] short-chain carboxylic acids,[3] metal-ion 
complexes,[10] inorganic anions,[26] and amino acids.[2,23] This paper extends this list to 
include herbicides, while also exploring the integration of EMLC and pH-modified mobile 
phases. 
One of the driving forces behind agrochemical research is the need for effective, low-
cost weed control using compounds which are environmentally benign. The s-triazines are a 
class of compounds that have been used for over forty years to control broadleaf and grassy 
weeds through disruption of photosynthesis pathways.[28] These molecules, as shown in 
Table 1, are based on a six-membered ring with nitrogen and carbon atoms linked by 
alternating single and double bonds. s-Triazines can also be grouped into subclasses based on 
their substituents: (1) atrazine, propazine and simazine are chloro-s-triazines; (2) prometon is 
a methoxy-s-triazine; and (3) ametryn, prometryn and terbutryn are methylthio-s-traizines. 
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The chlorinated triazines and their metabolites are, unfortunately, associated with possible 
cancer risks in humans and tumor incidence in animals,[29] and the methylthio-s-triazines 
are potentially toxic to aquatic organisms. As a consequence, the United States 
Environmental Protection Agency instituted a Special Review in 1994 that called for more 
research into the long-term environmental effects and metabolite degradation of these 
compounds.[30] 
While the gas chromatographic analysis of triazines is commonplace,[31] the polarity 
and low volatility of these compounds often dictate the use of derivatization steps prior to 
separation.[32] With recent advances in packing materials, liquid chromatography can be 
readily applied to separate herbicides without derivatization.[33,34] Drawing on this 
capability, liquid chromatography studies on triazine herbicides and their metabolites[35-43] 
have focused on realizing rapid and efficient separations. In addition to the LC work, 
research on optimizing extraction of triazines from soil [37,38,40,41] and utilizing mass 
spectrometry to better evaluate degradation products is enabling better herbicide 
monitoring.[39] Despite the advantages of LC, the separations can still be challenged by low 
resolution, owing to the strong interactions of these polar compounds with many stationary 
phases. Moreover, the structural similarity of the triazines and their metabolites can often 
lead to overlapping of elution bands. 
It has recently been shown that a highly effective separation of s-triazine herbicides in 
capillary zone electrophoresis can be achieved by optimizing the pH of the running 
buffer.[44] This approach takes advantage of the basicity of the nitrogens on the s-triazine 
aromatic ring, which can be protonated to impart a net positive charge.[45] Table 1, which 
lists the compounds that will be examined herein, summarizes this chemistry. This paper 
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investigates the impact of varying the pH of the mobile phase, as well as Eapp, on the 
separation of a mixture of s-triazines. These separations will employ a PGC stationary phase, 
which is stable between pH 1 and 14 and in a wide range of solvents,[27,46,47] as the 
column packing. The findings will also be examined with respect to the role of the mobile 
phase pH on the retention mechanism. 
 
EXPERIMENTAL 
2.1. Chemicals and Reagents 
The seven triazines, their abbreviations, and numeric labels are given in Table 1; all 
were purchased as the Triazine Neat Kit (49092) from Supelco (Bellefonte, PA, USA). The 
compounds were dissolved in methanol (HPLC-grade, Fisher, Pittsburgh, PA, USA) to a 
final concentration of 25 μM. Acetonitrile (HPLC-grade, Fisher) and deionized water 
(MilliPore Milli-Q system, 18Ω, Billerica, MA, USA), along with lithium perchlorate 
(Sigma-Aldrich, St. Louis, MO, USA), were used for all mobile phase preparations. In 
addition, 85% o-phosphoric acid (certified ACS, Fisher), glacial acetic acid (reagent grade, 
Fisher), sodium tetraborate decahydrate (ACS reagent, Sigma-Aldrich), and lithium 
hydroxide (reagent grade, Fisher) were employed to modify the pH of the mobile phase. 
Solutions of pH 4.00 (potassium hydrogen phthalate), 7.00 (potassium phosphate 
monobasic/sodium hydroxide), and 10.00 (potassium carbonate/potassium 
tetraborate/potassium hydroxide/disodium EDTA dihydrate) were acquired from Fisher. 
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2.2. Mobile Phase Preparation 
A series of preliminary experiments were performed to determine the most effective 
isocratic mobile phase composition for these separations. Separations were carried out with 
60%, 70%, 80% or 90% acetonitrile in water as mobile phases. These results indicated that a 
70% acetonitrile and 30% water mixture was a reasonable starting point based on tradeoffs 
between the duration and efficiency of separation. Thus, the standard mobile phase was 
prepared by dissolving lithium perchlorate (for solution conductivity) in 300 mL deionized 
water/700 mL acetonitrile to yield a 0.1 M solution. Prior to use, all mobile phases were: (1) 
passed through a 0.5-μm glass fiber filter (GE-Osmonics, Minnetonka, MN, USA) to remove 
any particulates; and (2) degassed for 30 min with high purity helium. 
 Three 100 mM buffer solutions were used [48-51]; phosphate buffer for pH 2, acetate 
buffer for pH 3 and 4, and borate buffer for pH 9. These buffers were chosen due to their 
solubility in the mixed mobile phase and optical transparency above 220 nm.[52] First, 300 
mL of buffer in water was prepared, and small adjustments in pH were made by addition of 1 
M (aq) lithium hydroxide. This step was followed by addition of lithium perchlorate (10.6 g) 
and 700 mL of acetonitrile in order to match the standard mobile phase. 
Measurements of pH were made with a standard glass electrode and meter (Orion 
model 520 A pH meter, Boston, MA, USA) and calibrated using pH 4.00, 7.00, and 10.00 
standards. After calibration, the pH of the buffer in the initial 300 mL of water ( pHww , purely 
aqueous mobile phase and water standards), as well as after organic modifier (acetonitrile) 
and lithium perchlorate ( pHsw , mobile-phase solvent relative to water standards), was 
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measured.[53] All pH values reported herein are as pHww , which is the most commonly used 
scale in the reverse phase HPLC literature.[48] 
  
2.3. EMLC Column 
The design of the EMLC column is shown in Figure 1, and the column construction 
has been detailed elsewhere.[16] In brief, 5-μm porous graphitic carbon (PGC, Thermo 
Hypersil, Runcorn, UK) is packed into a porous stainless steel (Mott Corp., Farmington, CT, 
USA) column (3.2 mm ID x 110 mm length) that has been lined with a Nafion (Perma Pure 
Inc., Toms River, NJ, USA) cation exchange membrane. The PGC stationary phase serves 
the working electrode (WE) while the Nafion tubing functions as the salt bridge to the 
external reservoir. This reservoir contains a silver/silver chloride (saturated sodium chloride) 
reference electrode, and all values of Eapp will be reported with respect to this reference. The 
Nafion membrane also electrically isolates the PGC and the porous stainless steel tube, which 
functions as a high surface area auxiliary electrode (AE). The connection to the WE is made 
through a stainless steel frit. The WE is, however, electronically isolated from the AE by a 
Kel-F ring that is inserted in a PEEK union and a PAT frit at the top of the column. 
 
2.4. Instrumentation 
The column was connected through standard, stainless steel endfittings to an Agilent 
Technologies (Palo Alto, CA, USA) model 1050 HPLC system, equipped with a solvent 
cabinet, autosampler, quaternary pumping system, and UV-Vis diode array detector. The 
samples were injected using a 5.0-µL loop, and elution profiles were monitored at 220, 230, 
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and 254 nm. The potential applied to the stationary phase was controlled with a Model 174A 
Polarographic Analyzer (Princeton Applied Research, Oak Ridge, TN, USA). 
 
2.5. Mode of Operation 
 The mobile phases were passed through the column at 0.4 mL/min until a constant 
baseline was reached after each change in mobile phase or Eapp. Duplicate injections were 
performed to assess the reproducibility of the separation. Individual analyte injections were 
used to determine the identity and elution times of each chromatographic band. Void time 
was determined by a methanol injection at each potential/mobile phase composition and was 
used for the calculation of the capacity factor (k’). To compensate for band tailing, retention 
times were determined from the first statistical moment analysis. In addition, resolution (Rs), 
as defined by the half-width peak method, with a value of 1.5 or greater is termed baseline 
resolution[54] and values between 1.0 and 1.5 are referred to as “effective resolution.”[26]  
 
RESULTS AND DISCUSSION 
3.1. Studies with pH Controlled Mobile Phases 
 As shown in Table 1, triazines can be protonated at the aromatic ring nitrogens. The 
acid strength of these compounds is strongly influenced by the substituents on the triazine 
ring: chlorotriazines have a pKa of ~2 and methoxy- and methylthiotriazines have a pKa of 
~4.[44,45,55,56] The differences in pKa values can be attributed to the high electronegativity 
of the chlorine group and resonance effects for the methoxy- and methylthiotriazines.[56] 
Since retention at PGC is manipulated by EMLC through a combination of donor-acceptor, 
dispersive, and solvophobic interactions,[13] this section of the paper examines the effects of 
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varying Eapp and changing the pH of the mobile phase on the separation of a seven-
component mixture.  
 
3.1.1. Mobile Phase pH of 2 
The results for the separation of the mixture with the pH 2 mobile phase (phosphate 
buffer, pHww =1.8) are presented in Figure 2. At the most positive value of Eapp (+400 mV), 
PZ, PY, and TY have overlapping elution profiles; AZ and AY have a similar problem. 
When moving to +200 mV, bands for all seven analytes become distinguishable, but the total 
time for separation is only marginally effected. By applying more negative potentials, the 
elution time of the methoxy- (PO) and methylthiotriazines (PY, TY and AY) become longer, 
whereas those of the chlorinated triazines (PZ, AZ, and SZ) are only marginally changed. 
Interestingly, the difference in the dependence of retention on Eapp causes a change in the 
elution order of the components in the mixture. 
 The results from this experiment are summarized in the top set of graphs of Figure 3 
in which the natural log of the capacity factor (ln k’) is plotted versus Eapp. Figure 3 also 
documents the sensitivity of retention (i.e., Δln k’/ΔEapp) for each compound. Qualitatively, 
the triazines with a pKa of ~4 should be protonated at pH 2, with AY, TY, PY, and PO then 
being positively charged. The elution times for these compounds should therefore increase as 
Eapp becomes more negative, reflecting the importance of electrostatic interactions on 
retention. This trend is observed in Figure 3. This behavior, however, is in contrast to that of 
the chlorotriazines (pKa ~2) which exist as a mixture with nearly equal proportions of their 
unprotonated and protonated conjugates. In this case, the retention of SZ, AZ, and PZ has 
smaller potential dependence. 
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3.1.2. Mobile Phase pH of 9 
 Next, the potential dependent retention of the triazines was evaluated at a mobile 
phase pH of 9 (borate buffer, pHww =9.2). At this pH, all the components of the mixture 
should be exhaustively deprontated and thus present as neutrals. The retention of the neutral 
molecules should then be governed mainly by interactions between the π-systems of the s-
triazine aromatic rings and the graphitic carbon stationary phase. Interestingly, the retention 
dependence on Eapp at pH 9 (bottom graph in Figure 3) is in stark contrast to that at pH 2. All 
seven compounds now undergo an increase in retention as Eapp moves to more positive 
values. 
There is another interesting point to draw from these data – the elution order of the 
analytes. As previously hypothesized,[13] neutral aromatic compounds interact with the 
carbonaceous stationary phase via an orientation that maximizes the π-system interactions. It 
then follows that triazine retention would be affected by any steric effects associated with 
bulky substituents. The plots at pH 9 are qualitatively consistent with this expectation in that 
shorter retention times are observed for the triazines with more bulky alkyl groups. In other 
words, PO, PZ, and PY elute first (R1=R2=isopropyl), followed by TY (R1=ethyl, R2=tert-
butyl), then AZ and AY (R1=ethyl, R2=isopropyl), and finally SZ (R1=R2=ethyl). 
 
3.1.3. Mobile Phase pH of 4 
 To further investigate the dependence of the EMLC separation on the acid-base 
chemistry of the triazines, the mobile phase was changed to pH 4 (acetate buffer, pHww = 
3.9). The results from this intermediate pH value are summarized by the middle set of plots 
 
124 
in Figure 3. In this scenario, the methylthiotriazines (AY, TY, and PY) should exist in a 
nearly equal distribution of their protonated and unprotonated forms. As found at pH 2, there 
is very little change in retention upon varying Eapp when the triazine exists in close to an 
equal proportion of its charged and neutral forms. PO, a methoxytriazine with pKa of 4.2, has 
a small, negatively valued sensitivity, which is qualitatively consistent with a slight excess of 
cations as opposed to the neutral form. For the chlorotriazines (SZ, AZ, PZ), which at pH 4 
should be present mainly in their unprotonated form, the sensitivity is slightly positive, with 
retention times tracking the π-interactions discussed in section 3.1.2. 
 The separations at this transitional pH, shown in Figure 4, also illustrate an unusual 
dependence on Eapp. As is evident, the methylthiotriazines (PY, TY, AY) remain at 
approximately the same elution time regardless of Eapp. However, as Eapp becomes more 
negative, the retention time of the chlorotriazines (PZ, AZ, SZ) decrease and that of the 
methoxytriazine (PO) increases. This “pulling apart” of the chromatogram leads to an 
effective resolution of the seven components at 0 mV. This phenomenon occurs because each 
analyte, as dictated by their equilibrium composition, respond differently to changes in Eapp. 
That is to say, the retention of PO will be manipulated mainly by electrostatics, the neutral 
compounds (PZ, AZ, SZ) will be governed by π-system interactions, and the equilibrium 
mixtures (PY, TY, AY) will be retained by the opposing competition of both types of 
interactions. This retention dependence is another of the unique features of EMLC as a 
separation technique, and we will look to take advantage of this effect in future work. 
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3.2. Effect of Acid-Base Equilibrium on k’ 
The acid-base equilibria of an analyte can affect k’ in a predictable manner.[57] In 
general, the equilibrium constant, Ka, for the mobile phase (m, solution concentrations) 
reactions in Table 1 between a triazine (Tr) and its corresponding cation (TrH+) can be 
expressed as 
[ ] [ ][ ]m mma TrH
HTrK +
+
=       (1) 
For retention at the stationary phase (s, interfacial concentrations), the equilibrium between 
the active sites on the carbon surface [C]s and the two forms of the triazine can be written as: 
[ ]
[ ] [ ]sm
s
TrC CTr
TrCK −=−       (2) 
[ ][ ] [ ]sm sTrHC CTrH
TrHCK +
+
−
−=+      (3) 
where [C-Tr]s and [C-TrH+]s signify the reversible association between the neutral and 
protonated forms of the triazines, respectively, and PGC. These theoretical considerations 
neglect any acid-base chemistry for PGC.[46] The overall capacity factor can then be 
determined by the distribution of the analyte between the stationary and the mobile phases: 
[ ] [ ][ ] [ ]mm ss TrTrH
TrCTrHCk +
−+−= +
+
φ'      (4) 
where φ  is the phase ratio for the stationary and mobile phase volumes. By solving equations 
1-3 for [TrH+], [C-Tr], and [C-TrH+], respectively, and substituting these results into 
equation 4, the dependence of k’ on the acid-base chemistry can be written as: 
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k φ    (5) 
This expression can be further refined by defining the capacity factors for the unprotonated 
( Trk ' ) and protonated ( +TrHk ' ) forms of the triazines through equations 2 and 3: 
[ ]
[ ] [ ] TrCsm
s
Tr KCTr
Trk −== φφ'      (6) 
[ ][ ] [ ] ++ −+
+
== TrHCs
m
s
TrH KCTrH
TrHk φφ'     (7) 
Upon substitution of equations 6 and 7 into equation 5, we arrive at: 
[ ]
[ ]
[ ]
[ ][ ]
[ ]m
m
m
m
TrHTr
a
m
a
m
TrHTr
Tr
TrH
Tr
TrHkk
K
H
K
Hkk
k +
+
+
+
+
+
=
+
+
=
++
1
''
1
''
'   (8) 
The two forms of equation 8 can therefore be used to qualitatively explain the 
dependencies observed in Figure 3. The results for AY, summarized in Figure 5, serve as an 
example. At pH 1.8, which is about two pH units less than the pKa, AY is cationic and 
therefore migrates largely via the +TrHk '  term in Equation 8. As a consequence, as more 
negative values of Eapp are used, the cationic triazine is more strongly retained by PGC. Upon 
adjusting the pH to more basic values, the distribution of AY shifts towards its neutral form, 
and +TrHk '  contributes less to the overall capacity factor. This dependence was verified by 
adjusting the mobile phase pH from 1.8 to 2.6 (both pH<pKa), which decreases the 
importance of electrostatic interactions but increases the role of π-system interactions. 
Indeed, the separations at pH 2.6, as shown for AY in Figure 5, exhibited a less negative 
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slope. At pH 3.9, the two conditions essentially compete, and the overall capacity factor does 
not have a significant change with respect to the potential applied. 
At pH 9.2, all the analytes are neutral, and equation 8 is controlled by Trk ' . The 
positively sloped dependence of retention on Eapp is primarily due to interactions from the π-
system of the triazine ring and PGC. It is important to note, however, that the retention times, 
and thus ln k’, for the separations at different pH mobile phases cannot be directly compared 
because, as previous work has shown,[24,25] dissimilar electrolytes have varied elution 
strengths.  
Another interesting result can be developed by plotting the sensitivities from the data 
in Figure 3 versus the mobile phase pH. Figure 6 shows such a plot for AY. This graph 
illustrates via Equation 8 that the pKa of the molecule can be determined at the inflection 
point of curve to the sensitivities at each mobile phase pH. To obtain the inflection point, the 
best fit line for each retention regime (i.e., electrostatic domain at low pH and π-systems 
interactions at high pH) was determined and the intersection of these two lines was 
calculated. The intersection is at pH 3.4 pH indicates that the pKa is slightly lower than the 
published value of 4.05.[44] This analysis was also applied to the other triazines, with PO, 
PY, and TY having respective pKa values of 3.5, 3.3, and 3.3. These results are lower than 
the published pKa values, which we attribute to the presence of acetonitrile, a lower dielectric 
solvent than water, in the mobile phase.[46] We note that assessments for PZ, AZ, and SZ 
were not possible because the mobile phase solutions were not acidic enough to determine a 
transition. This result indicates that EMLC can also be used to determine fundamental 
properties of molecules, an avenue of exploration which in currently underway. 
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3.3 Rapid Separation of Triazines 
As a final set of experiments, the EMLC conditions were optimized and a rapid 
separation was performed under normal mobile phase conditions. As discussed previously, 
the retention of uncharged s-triazines is strongly affected by interactions between the π-
systems of the triazines and those of PGC. Representative chromatograms from the 
separation of the triazine mixture are presented in Figure 7. The open-circuit potential (OCP) 
for this column and mobile phase is +150 mV. When operating slight more positive than the 
OCP (+200 mV), two sets of analytes have overlapping elution profiles, and the separation 
requires 14 min. These results elucidate the challenge posed by the separation of these polar, 
structurally similar compounds.  
By taking advantage of the ability to manipulate the interactions between the column 
packing and analyte via changes in Eapp, elution times can be decreased, and, interestingly, 
the resolution of the separation can be improved due to altered selectivity at different 
potentials. This effect is in contrast to conventional LC in that a decrease in retention usually 
results in a loss of resolution. This advantage of EMLC provides improvements in both time 
and resolution in the separation of this mixture to the extent that at -600 mV near baseline 
resolution (Rs between 1.3 and 4.7 for adjacent bands) of the seven components solution 
occurs in under eight minutes. Recent examples using reverse phase packing, however, 
require roughly twice the time, with little improvement over the resolution seen at -600 
mV.[36,37,39] 
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CONCLUSIONS 
The separation and retention characteristics of the triazine molecules were found to be 
strongly influenced by mobile phase pH. Under pH control, the separation of the triazine 
analytes showed marked changes in their sensitivity toward Eapp that reflected the distribution 
of the conjugated acid-base forms of the compounds. We believe these results show that 
EMLC can not only be used to perform separations but also as a research tool to probe 
physical properties and processes. From the separation standpoint, near-baseline resolution of 
the seven triazines was realized in under eight minutes by taking advantage of the ability to 
manipulate Eapp. Further work to extend the use of pH in EMLC to other systems is currently 
being performed. Research is also underway to more fully understand the mechanisms that 
govern the retention of the triazine compounds, with the ultimate goal being to form a set of 
global pH/EMLC retention rules. 
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FIGURES 
Fig. 1. Schematic of EMLC column 
 
Table 1 
s-Triazine analyte names, acronyms, structures, and pKa values along with the corresponding 
equilibrium. 
 
Fig. 2. Separation of standard triazine mixture with mobile phase at pH 2 (phosphate buffer). 
Flow rate 0.4 mL/min with 0.1 M LiClO4, 70% acetonitrile, 30% water mobile phase. 
Potential applied versus Ag/AgCl sat’d NaCl with λdet at 220 nm. Analyte concentrations are 
25 μM with 5-μL injection volume. 
 
Fig. 3. Separation of standard triazine mixture with mobile phase at pH 2 (phosphate buffer), 
pH 4 (acetate buffer), and pH 9 (borate buffer). Experimental conditions same as Figure 2 
and N=3 for each data point. 
 
Fig. 4. Separation of standard triazine mixture with mobile phase at pH 4 (acetate buffer). 
Experimental conditions same as Figure 2 but λdet at 230 nm. 
 
Fig. 5. Effect of changing mobile phase pH on the retention of ametryn with the natural log 
of capacity factor versus applied potential for pH 1.8 (phosphate buffer), pH 2.6 and 3.9 
(acetate buffer), and pH 9.2 (borate buffer). Other conditions same as Figure 2. 
 
Fig. 6. Slope from natural log of capacity factor versus applied potential (Figure 5) for 
ametryn. Smooth curve through these points crosses x-axis at pH ~4.1. 
 
Fig. 7. Separation of standard triazine mixture with no pH control. Experimental conditions 
same as Figure 2. Elution order for separations at Eapp of -200 through -600 mV is: PO, PZ, 
PY, TY, AZ, AY, and SZ. 
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CHAPTER 6: Conclusions 
This dissertation focused on research aimed at advancing two analytical techniques. 
Chapter 1 gave a general introduction to detection techniques for bacteria as well as an 
overview of Raman spectroscopy and instrumentation. Work to improve heterogeneous 
immunoassays that rely on surface-enhanced Raman scattering (SERS) readout was the focus 
of Chapters 2-4 while electrochemically modulated liquid chromatography (EMLC) method 
development and applications were investigated in Chapter 5 and the Appendix. 
Advances in SERS readout immunoassays. The first body of work focused on the 
modification of a SERS-based sandwich immunoassay, previously developed in our group, in 
order to detect Mycobacterium avium subspecies paratuberculosis (MAP). This bacterium is 
the etiological agent of Johne’s disease and is responsible for large economic losses in the 
cattle industry. Current diagnostic measures, however, do not adequately detect the bacteria 
and many are not readily field deployable, and thus timely implementation of counteractions 
to control the spread of disease is not possible. To improve upon current transduction 
methods, a SERS readout assay for the detection of MAP was developed and discussed in 
Chapters 2 and 3.  
Chapter 2 focused on optimizing the current immunoassay with attention on antibody 
selection and blocking buffer conditions. Results for the K-10 MAP sonicate showed levels 
of detection (LOD) on the order of 1500 ng/mL which translated to ~750 MAP/mL. This 
assay was extended to the corresponding heat-killed, whole cell bacteria in Chapter 3 and had 
a LOD of ~500 MAP/mL. An interesting discovery revealed during the course of this 
investigation was the possibility of protein shedding from the surface of a bacterium cell. 
When viewed as an internal amplification mechanism, this development holds the potential 
 
142 
for improvements in LODs in other bacterial assays. The limits of detection achieved by 
these sensors, as well as the specificity and quantitative nature of the method, will allow for 
earlier diagnosis of infection and enhanced tracking of disease progression. 
As a pathway to achieving improved limits of detection, methods to increase the 
signal intensity from our extrinsic Raman labels (ERLs) were investigated in Chapter 4. 
Research has shown that when a molecule has an electronic band in tune with the excitation 
laser wavelength, the scattering probability is increased and thus the Raman signal intensity 
also increases. Based on this, research was conducted on incorporating commercially 
available dyes (resonant molecules) into the ERLs. One of the major challenges in this work 
centered on maintaining the stability of the colloidal suspension during incorporation of the 
resonant molecules. Through adjusting the nanoparticle labeling protocol, a stable colloidal 
suspension was achieved. When the new ERLs were used in the SERS readout immunoassay, 
signals for the resonant Raman labels were ~300 times more intense than their nonresonant 
counterpart. However, improved limits of detection were not realized in this study, as the 
blank signals used to calculate the LOD were dominated by nonspecific binding. 
Investigations of EMLC mobile and stationary phases. The second portion of this 
dissertation described advances made to EMLC. This analytical tool combines liquid 
chromatographic methods with potential control of the stationary phase. To further advance 
this technique, methods to implement pH modified mobile phases into EMLC were discussed 
in Chapter 5. By performing separations under different pH conditions, changes in elution 
order could possibly be achieved. To investigate this, seven triazine herbicides that are 
potentially hazardous to humans and the environment were utilized, as the pKa values of 
these molecules are dominated by their individual substituents. As such, this class of 
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compounds was used to model pH control in EMLC, and equilibrium considerations were 
discussed. An interesting outcome of this research was the elucidation of “pulling apart” a 
chromatogram. That is to say, when potential was changed two previously coeluting 
compounds could be separated as one analyte had a decrease and one had an increase in 
elution time. This unique aspect of EMLC could allow for improved separations of 
structurally similar compounds. 
Finally, the Appendix briefly discussed the integration of novel, monolithic stationary 
phases into EMLC. The column was redesigned and preliminary studies were performed with 
porous, rod-like stationary phases. While these investigations did not lead to improvements 
in the current system, the results have allowed a redirection in the focus of EMLC column 
construction and synthesis of monolithic phases for EMLC. 
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APPENDIX. Monolithic Carbon as a Novel Stationary Phase for 
Electrochemically Modulated Liquid Chromatography 
Betsy Jean Yakes and Marc D. Porter 
 
 
INTRODUCTION 
Stationary phase development in liquid chromatography is essential for improvements 
in chromatographic performance. Traditional, particulate packed phases are limited by large 
void volumes, slow mass transfer of large molecules, or high back pressure.1 To improve 
upon these limitations, an exciting new area of study focuses on transitioning from slurry 
packed materials to contiguous foam-like phases.2 While multiple names exist to describe 
these materials, the term monolith, stemming from the Greek μονολιτηοσ for single (μονο) 
stone (λιτηοσ), has become the most widely accepted.3 The fused design of these materials 
yields both high permeability and high efficiency while also having low resistance to fluid 
flow. An additional attribute, which could be advantageous with electrochemically 
modulated liquid chromatography (EMLC), is that monolithic phases may lead to a lower 
solution resistance and, with more consistent pore size, more uniform resistance across the 
column. 
Monoliths are generally classified as polymer- or silica-based and are further grouped 
by the derivatives used during synthesis or any subsequent surface modification. There are a 
diversity of pathways for the preparation of these phases with hydrogels, polyurethane foams, 
compressed beads, thin disks, and rigid columns being the most popular formats.3 Unlike 
polymer- and silica-based materials, purely carbon monolithic stationary phases (i.e., 
monolithic carbon, MC) have been introduced only recently. These monoliths are generally 
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synthesized by using a silica template and a carbon precursor.4-8 After the precursor is 
carbonized under non-oxidizing conditions, the silica framework is dissolved. Since the 
shape of the MC is based solely upon the silica template and the surrounding support, the rod 
length, width, shape, and internal pore diameter can be tailored to suit many column designs. 
One such carbon monolith by Guiochon and coworkers is formed through high-temperature 
graphitization of a phenolic resin rod with embedded sacrificial silica beads. The resulting 
porous rod consists of a bridged framework of highly ordered carbon with both micro- and 
mesopores.5 With the goal of exploring the benefits of MC, we investigated this and similar 
monolithic columns, in collaboration with Guiochon and coworkers, with our EMLC system.  
EMLC, as introduced in Chapter 5, is a unique combination of liquid chromatography 
and electrochemistry. In EMLC, analyte retention is manipulated by changing the potential 
applied (Eapp) to a conductive stationary phase such as porous graphitic carbon (PGC). While 
MC is a conductive material like PGC, its structure provides a packing with more regular 
channels than slurry packed columns, yielding a lower level of axial dispersion and 
potentially improved separations. The focus of this appendix is on attempts to assess the 
potential of these MC stationary phases in EMLC. This report is intended to serve as a record 
of the research, with experimental conditions and prospective studies as guidelines for future 
investigations. 
 
GLASSY CARBON PARTICULATE ROD 
 Our first attempt at incorporating monoliths as stationary phases used a preformed 
particulate rod synthesized through phase separation procedures. This fused material was 
similar to, but easier to synthesize than, a skeletal monolithic rod and functioned as a good 
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mechanical model for use in redesigning the column. SEM images of this rod, shown in 
Figure 1, indicated that the material was composed of clusters of ~1-μm beads that were 
stacked together. These rods were composed of ungraphitized, glassy carbon and had a 
surface area of ~200 m2/g, determined by BET measurements (C. Liang and S. Dai, Oak 
Ridge National Laboratory). In addition, their studies showed chromatographic performance 
with this material was poor due to micropores in the particle surface (unpublished data). To 
improve performance, the number of micropores can be decreased through graphitization or 
surface modification. For the scope of this investigation, this rod was used as a model for 
redesigning the column; however, since the material was not capped, the rod was not 
extensively used for separations. 
  
REDESIGNED EMLC COLUMN 
 The standard EMLC column and HPLC instrumentation have been detailed in 
Chapter 5. This basic column9 format, having been optimized for slurry packing particulate 
stationary phases, required redesign for incorporation of the MC rods. In the traditional 
EMLC column, a stationary phase is packed into a porous stainless steel column housing that 
 
 
Figure 1. Glassy carbon rod SEM images. 
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has been lined with a Nafion cation exchange membrane. The conductive stationary phase 
serves as the working electrode (WE), while the Nafion tubing functions as the salt bridge 
and electronic insulator between the working and auxiliary electrodes. The porous stainless 
steel provides the structural support for the column and provides the high surface area 
auxiliary electrode (AE). To complete the three electrode electrochemical cell, a silver/silver 
chloride (saturated sodium chloride) reference electrode (RE) is placed in an external 
electrolyte reservoir. This setup of building the column from the outside-in, however, was not 
readily amenable to use with preformed rods. As such, the standard EMLC column needed to 
be rebuilt from the inside-out. Throughout the alteration process, efforts were made to ensure 
the column housing remained as close as possible to the traditional setup so that comparisons 
between the monolithic phases and PGC could be made. 
The first step in modifying the column 
was machining the stainless steel housing. In this 
case, the rods encapsulated with Nafion were a 
larger diameter (~3.8 mm) than the column body 
(3.2-mm internal diameter, i.d.), so the stainless 
steel was bored out to a ~3.9-mm i.d. with the 
11-cm length maintained. Next, one end of the 
Nafion tubing that encases the stationary phase 
was flanged. After flanging, a wooden rod was 
inserted into the tubing, and the Nafion tubing was completely immersed in isopropanol. This 
process maintained the shape of the tubing while swelling the polymer to make it more 
pliable. Once this occurred, the wooden rods were removed, and the monolithic rod was 
 
 
Figure 2. Modified EMLC column 
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inserted into the Nafion tubing. This procedure was done by manually sliding/twisting 
Nafion tubing over the rod while continuously wetting the Nafion/rod structure with 
isopropanol to decrease friction. During this process, special care was taken to ensure the 
Nafion tubing did not wrinkle and that the flange was not distorted. When the top of the rod 
was flush with the flange, the assembly was dried (2 h, room temperature), placed in the 
column body, and the nonflanged end of the Nafion/rod cut flush with the end of the column. 
To form a seal at the bottom of the column, a flange was formed from heat-shrink Teflon, 
inserted between the Nafion tubing and stainless steel, and then heated to form a seal. The 
finalized column, shown schematically in Figure 2, was fitted with standard frits and end 
fittings and attached to the HPLC instrumentation and potentiostat as described in Chapter 5. 
Results from experiments with this rod indicated that the material was a poor 
chromatographic stationary phase as 
expected based on the unblocked 
micropores. When using a 100 mM 
lithium perchlorate, 95% water, 5% 
acetonitrile mobile phase at a flow rate 
of 1.0 mL/min, the backpressure was 
only 30 bar. In addition, injections of 
acetonitrile and benzene sulfonate had 
the same elution times as shown in Figure 3. These results indicated that the analytes did not 
sufficiently interact with stationary phase. Based on this, further separations were not 
performed with this material. However, the EMLC column modification did allow for 
incorporation of the rod, so skeletal monoliths were tested next. 
 
 
Figure 3. Experiments with glassy carbon rod. 
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MONOLITHIC CARBON  
The MC rod used for separation studies is shown in the SEM images in Figure 4. 
SEM images illustrated the skeletal structure (Figure 4a and 4c) as well as the mesoporous 
features observed with a lower accelerating voltage (Figure 4b). Characterization of this 
material by Raman spectroscopy (Figure 4d) gave two broad bands. The lower energy band 
is attributed to carbon disorder and is characteristic of nongraphitic carbon; however, the 
presence of the E2g breathing mode at 1526 cm-1 indicates a degree of microcrystallinity.10 
This conductive material was inserted into the redesigned EMLC column and separations 
were performed with a mixture of aromatic sulfonates. As shown in Figure 5a, the analytes 
had no detectable retention and appeared to coelute with the void volume. In addition, at the 
flow rate of 1 mL/min, the back pressure was only 45 bar, and the void volume was 
calculated to be ~0.3 mL. This situation may reflect gaps between the Nafion and stationary 
phase, creating a low resistance flow path for the mobile phase that would allow the analyte 
to flow past the stationary phase. In addition, this material was nongraphitized and contained 
micropores similar to the glassy carbon, particulate rod. As mentioned above, these 
micropores lead to poor chromatographic efficiency but can be capped by either 
graphitization or surface modification; however, these procedures were not preformed within 
the scope of this investigation. 
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Another possible explanation of the lack of retention is the complete adsorption of the 
analytes to the stationary phase. To test this hypothesis, experiments were performed with 
varying concentrations of benzene sulfonate. The only elution band found was at the void 
volume. In addition, as shown in Figure 5b, the area under the elution band tracked linearly 
with the benzene sulfonate concentration, supporting the premise of the analyte eluting in the 
void band. This result points to either gaps between the stationary phase and Nafion/column 
housing and/or the existence of micropores as the complication. The presence of gaps has 
been the primary challenge in integrating monolithic materials into chromatography, but 
could be overcome by monolith formation in-situ and the subsequent covalent bonding of the 
monolith to the support (e.g., column housing).11 For the possibility of micropores hindering 
 
Figure 4. SEM images and Raman spectrum of nongraphitic, monolithic carbon rod. 
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retention, this would be best overcome by graphitizing the carbon surface, as surface 
modification could interfere with the conductivity of the carbon surface. 
 
FUTURE DIRECTIONS 
 As these initial studies show, redesigning our traditional EMLC column to 
incorporate rod stationary phases did not readily result in a functioning chromatographic 
system. The main challenges to this approach included chipping or cracking the rod during 
insertion into the Nafion tubing and ensuring that there were no gaps between the monolith 
and Nafion membrane. There are two avenues to potentially mitigate these difficulties. The 
first path addresses a dramatic column redesign that would not only allow simpler 
encapsulation, versus insertion, of preformed stationary phases but also include a completely 
enclosed electrolyte reservoir. The self-contained electrolyte reservoir will also enable easier 
column integration (e.g., incorporation into standard HPLC column compartments) and use 
in high temperature environments with limited evaporation of electrolyte. The second area 
takes advantage of monolith stationary phase formation and will focus on developing 
 
Figure 5: (a) Separation with a mixture of benzene sulfonate (BS), methyl- (MBS), 
chloro-BS (CBS), and hydroxy-BS (HBS), each 20 μM. (b) BS injects at varying 
concentrations and corresponding peak area at ~0.3 min (other conditions in a). 
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methods for synthesizing carbon monoliths within the Nafion, or similar, encasings. Such an 
approach would potentially avoid the formation of gaps possibly encountered during this 
study. In addition, since micropores may have limited the chromatographic ability of the rods 
used herein, the next generation of monolithic materials should be graphitized. 
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